Stockwinners Market Radar for August 21, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
NTR | Hot Stocks20:20 EDT Nutrien gets ACCC approval for Ruralco acquisition - Nutrien obtained the Australian Competition and Consumer Commission's approval to proceed with its acquisition of Ruralco Holdings. With regulatory approval received from the ACCC, the transaction now requires approval from the Australian Foreign Investment Review Board. Upon securing the necessary approvals from the FIRB, as well as Ruralco shareholders, the transaction is anticipated to be completed on September 30, 2019.
|
ATKR | Hot Stocks19:59 EDT Atkore buys Rocky Mountain Colby Pipe Company, terms not stated - Atkore announced that it has acquired the assets of Rocky Mountain Colby Pipe Company, "a leader in PVC conduit and duct products sold under the Cor-Tek brand name". Rocky Mountain Colby Pipe is headquartered in Pendleton, Oregon, and will continue operating at its current location. Terms of the sale are undisclosed.
|
F... | Hot Stocks19:37 EDT Trump tweets California will 'squeeze' automakers to business ruin - In response to automakers' deal with California regulator on miles-per-gallon minimums, President Trump tweeted: "Henry Ford would be very disappointed if he saw his modern-day descendants wanting to build a much more expensive car, that is far less safe and doesn't work as well, because execs don't want to fight California regulators. Car companies should know that when this Administration's alternative is no longer available, California will squeeze them to a point of business ruin. Only reason California is now talking to them is because the Feds are giving a far better alternative, which is much better for consumers!"
|
AMZN | Hot Stocks19:06 EDT Amazon Web Services announces general availability of Amazon Forecast - Amazon Web Services announced the general availability of Amazon Forecast, a fully managed service that uses machine learning to deliver highly accurate forecasts based on the same technology that powers Amazon.com. Amazon uses forecasting to make sure that the right product is in the right place at the right time by predicting demand for hundreds of millions of products every day. Amazon Forecast uses this same technology to build precise forecasts for virtually any business condition, including product demand and sales, infrastructure requirements, energy needs, and staffing levels - with predictions that are up to 50% more accurate than traditional methods. Amazon Forecast is easy to use and requires no machine learning experience. The service automatically provisions the necessary infrastructure, processes data, and builds custom, private machine learning models that are hosted on AWS and ready to make predictions. Amazon Forecast is available today in US East (Ohio), US East (N. Virginia), US West (Oregon), Asia Pacific (Tokyo), Asia Pacific (Singapore), and EU (Ireland) with more availability zones coming soon.
|
JWN... | Hot Stocks19:03 EDT Fly Intel: After Hours Movers - UP AFTER EARNINGS: Nordstrom (JWN) up 11.6%... Keysight (KEYS) up 7.0%... Synopsys (SNPS) up 2.4%... Pure Storage (PSTG) up 1.7%... Splunk (SPLK) up 0.3%. ALSO HIGHER: Jumia Technologies (JMIA) up 4.6% after being upgraded at RBC... Etsy (ETSY) up 2.5% after being upgraded to Buy at Stifel... Wanda Sports (WSG) up 2.3% after being initiated with a Buy at Loop Capital... Wayfair (W) up 1.7% % after being upgraded to Buy at Stifel. DOWN AFTER EARNINGS: Huanzhu Group (HTHT) down 5.2%... L Brands (LB) down 0.3%. ALSO LOWER: Avinger (AVGR) down 19.2% after equity offering. Movers as of 18:45ET.
|
EQIX | Hot Stocks18:47 EDT Equinix CEO: Trade tensions have not impacted demand for our business - In an interview on CNBC's Mad Money, Equinix CEO Charles Meyers said: We see real strength across the business right now... People are prioritizing digital transformation... We think there is deep demand for data centers, broadly speaking... The interconnection story is a big part of our history... We may not be a household name, but we're impacting the lives of many people... Retail is a strong segment for us.
|
PAYC | Hot Stocks18:22 EDT Paycom CEO: We are very focused on the employee - In an interview on CNBC's Mad Money, CEO Chad Richison said: We are transforming the HR/payroll industry... We allow employees to have a direct relationship with the database... We allow HR to remove themselves from the data process... We are in growth mode... The economy has been strong... We are getting a lot referrals from rank and file employees who are familiar with our service.
|
EW | Hot Stocks18:04 EDT Edwards Lifesciences director sells 10.2K shares of common stock - In a regulatory filing, Edwards Lifesciences disclosed that its director William Link sold 10.2K shares of common stock August 20th-21st. The total transaction size was over $2.2M.
|
PSTG | Hot Stocks17:57 EDT Pure Storage CFO Officer Tim Riitters to leave company - CFO Tim Riitters will be departing the company this year after a successful five-year tenure. Riitters will remain on into the Fall as the company undergoes the search for a replacement CFO. Riitters first joined Pure in August 2014, assuming leadership of the company's worldwide financial and accounting operations. In that time, he has helped drive an increase in revenue of nearly 10x, while also helping the company achieve profitability.
|
NOC | Hot Stocks17:55 EDT Northrop Grumman awarded $101.1M Army contract modification - Northrop Grumman was awarded a $101.1M modification to a contract for contractor logistics support services. Work will be performed in Herndon, Virginia, with an estimated completion date of August 31, 2020. FY19 operations and maintenance, Army funds in the amount of $34.04M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.
|
BA | Hot Stocks17:53 EDT Boeing awarded $145.89M Army contract modification - Boeing was awarded a $145.89M modification to a foreign military sales contract for the remanufacture of 11 aircraft and new build Longbow crew trainer and spares. Bids were solicited via the internet with one received. Work will be performed in Mesa, Arizona, with an estimated completion date of March 29, 2024. FY10 foreign military Sales funds in the amount of $145.89M were obligated at the time of the award. U.S. Army Contracting Command is the contracting activity.
|
RTN | Hot Stocks17:50 EDT Raytheon awarded $190.52M Navy contract modification for ESSM materials, spares - Raytheon has been awarded a $190.52M fixed-price-incentive firm and firm-fixed-price modification to a previously-awarded contract for materials and spares in support of FY19 evolved sea sparrow missile, or ESSM, block 2 low-rate initial production requirements. This contract will procure the remaining materials in support of the ESSM FY19 low-rate initial production lots one through three all-up rounds and spares requirements. The ESSM program is an international cooperative effort to design, develop, test and procure ESSM missiles. The ESSM provides enhanced ship defense. Work is expected to be completed by March 2023. Non-expiring other funds; FY19 and FY18 weapons procurement and fiscal FY18 and FY17 other procurement funding in the amount of $200.62M will be obligated at time of award and funding in the amount of $105,890 will expire at the end of the current fiscal year. The Naval Sea Systems Command is the contracting activity.
|
BA | Hot Stocks17:46 EDT Boeing awarded $999M Air Force contract for A-10 wing replacements - Boeing has been awarded a $999M indefinite-delivery/indefinite-quantity contract for A-10 wing replacements. This contract provides for up to 112 new A-10 wing assemblies and up to 15 wing kits. Work will be performed at multiple subcontractor locations in the U.S. and one subcontractor location in South Korea and is expected to be complete by August 23, 2030. This award is the result of a competitive acquisition and two offers were received. FY17, FY18 and FY19 procurement funds in the amount of $239.58M and are being obligated at the time of award. The Air Force Life Cycle Management Center is the contracting activity.
|
COLM | Hot Stocks17:32 EDT Columbia Sportswear announces $33M global headquarters expansion - Columbia announced the expansion of its campus in Washington County, Oregon. The company purchased three buildings from Electro Scientific Industries, all of which are located within a quarter of a mile from the main headquarters, directly beside the Columbia Sportswear employee store. At $33M, this acquisition will add more than 200,000 square feet to Columbia's existing presence, with one building scheduled to be delivered by June 2020 and the other two by June 2021.
|
PNW | Hot Stocks17:31 EDT Pinnacle West CEO Don Brandt to retire in November - Pinnacle West announced that after 16 years with the company, Pinnacle West Chairman, President and CEO Don Brandt will retire effective November 15, 2019. The board elected current APS President Jeff Guldner to the board effective immediately, and appointed him chairman of the board, Pinnacle West President and CEO, and APS CEO succeeding Don Brandt in those capacities effective November 15, 2019. Guldner will continue to serve as President of APS.
|
GLD | Hot Stocks17:27 EDT SPDR Gold Shares holdings rise to 851.91MT to 845.17MT - This is the second consecutive increase in holdings and the highest level since May of 2018.
|
MGRC | Hot Stocks17:26 EDT McGrath RentCorp CFO Keith Pratt sells over $265K in company shares - McGrath RentCorp CFO Keith Pratt disclosed in a filing that he had sold 3,951 shares of company stock at an average price of $ $67.09 per share between August 19 and August 21. The total transaction value of the sale was $ $265,072.
|
KPTI | Hot Stocks17:24 EDT Karyopharm selinexor phase 2b data published in NEJM saw 26% response rate - Karyopharm announced that the results of the Phase 2b STORM study evaluating XPOVIO, or selinexor, in patients with heavily pretreated, triple class refractory multiple myeloma were published online today in the New England Journal of Medicine. The STORM study evaluated XPOVIO, the company's first-in-class, oral SINE compound, and low-dose dexamethasone in patients with triple class refractory multiple myeloma who were previously treated with all five of the most commonly prescribed anti-myeloma therapies currently available. XPOVIO received accelerated approval in the U.S. from the FDA on July 3, 2019 for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody. This indication is approved under accelerated approval based on response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. Sundar Jagannath, MD, Tisch Cancer Institute at Mount Sinai School of Medicine, principal investigator of the STORM study and co-lead author of the manuscript, said, "The data from the STORM study demonstrate that oral selinexor, a first-in-class XPO1 inhibitor, combined with dexamethasone twice weekly, resulted in a response rate of 26% in heavily pretreated patients. The characteristics of the patients in the STORM study, including being heavily pretreated, yet still experiencing rapidly progressing disease, are consistent with the growing population of patients who have exhausted available myeloma therapies, but still desire to continue therapy. Of particular significance, for the 39% of patients who had a minimal response or better, overall survival was 15.6 months, compared to 1.7 months in patients whose disease progressed or where response was not evaluable."
|
SKT | Hot Stocks17:06 EDT Tanger Factory director David Henry buys 10K shares of company stock - Tanger Factory director David Henry disclosed in a filing that he had purchased 10,000 shares of company stock at an average price of $14.41 per share on August 21. The total transaction value of the purchase was $$144,090.
|
JWN | Hot Stocks17:05 EDT Nordstrom says tariff impact will be relatively immaterial for the year - Says saw improvement in Nordstrom note redemption. Says ended Q2 with strong inventory position. Says increasing high-quality flash events. Says pleased with results in Los Angeles. Say will open three stores in New York City and leverage existing stores there. Says well positioned for second half. Says there was a change in customer behavior this year. Says saw more demand for top items than before. Says company could have had deeper position in its top items. Comments taken from Q2 earnings conference call.
|
FRGI | Hot Stocks17:02 EDT Fiesta Restaurant names Dirk Montgomery as new CFO - Fiesta Restaurant named Dirk Montgomery as its new CFO, effective September 9, 2019. Mr. Montgomery has over a decade of restaurant industry experience, most recently as Chief Financial Officer of Hooters International.
|
SMPL | Hot Stocks17:02 EDT Simply Good Foods up 2.4% after announcing it will acquire Quest Nutrition
|
USEG | Hot Stocks17:01 EDT U.S. Energy receives Nasdaq notice regarding non-compliance - U.S. Energy Corp. notified the company on August 16, 2019 that it is not in compliance with NASDAQ Listing Rule 5250c1 for continued listing due to the delay in filing its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2019. Previously, NASDAQ had granted the company an exception until September 16, 2019 to file its delinquent Annual Report on Form 10-K for the year ended December 31, 2018 and until October 14, 2019 to file its delinquent Quarterly Reports on Form 10-Q for the periods ended March 31, 2019 and June 30, 2019, subject to the company submitting to NASDAQ the company's plan to regain compliance with NASDAQ's filing requirements. The notification from NASDAQ notes that U.S. Energy is required to submit to NASDAQ an update to its plan to regain compliance with filing requirements for continued listing no later than September 3, 2019 for the NASDAQ staff to review.
|
SMPL | Hot Stocks17:00 EDT Simply Good Foods trading resumes
|
MICR | Hot Stocks16:57 EDT Micron Solutions announces compliance plan acceptance letter from NYSE American - Micron Solutions announced acceptance of its compliance plan by the NYSE American LLC. On August 16, 2019, the company received a letter from NYSE Regulation American stating that they have reviewed the company's July 12, 2019 compliance plan and supplemental submissions, accepted the plan and granted a plan period through December 12, 2020. As previously announced on June 18, 2019, the company is not in compliance with the NYSE American continued listing standards. The company's listing is being continued pursuant to an extension. In order to maintain its NYSE listing, the company must provide quarterly updates to NYSE Regulation staff concurrent with its interim and annual SEC filings and at other times around plan initiative milestones. If the company is not in compliance with the continued listing standards by December 12, 2020, or if the company does not make progress consistent with the plan during the plan period, NYSE Regulation staff will initiate delisting proceedings as appropriate. The company may appeal a staff delisting determination in accordance with Section 1010 and Part 12 of the NYSE American Company Guide. The company's management intends to fully comply with the supplemental reporting requirements of the Exchange.
|
TLGT | Hot Stocks16:53 EDT Eversept Partners reports 5.01% passive stake in Teligent - In a regulatory filing, Eversept Partners disclosed a 5.01% stake in Teligent, which represents about 2.7M shares. The filing does not allow for activism.
|
AFG | Hot Stocks16:47 EDT American Financial Group increases annual dividend 12.5% to $1.80 per share - American Financial Group has approved an increase in the company's regular annual dividend from $1.60 to $1.80 per share of common stock. The increased dividend, when declared, will be paid on a quarterly basis of 45c per share of common stock beginning in October 2019. The new dividend rate represents a 12.5% increase over the annual rate paid thus far in 2019.
|
JWN | Hot Stocks16:45 EDT Nordstrom says one-third of customers visit a store before purchasing online - Says 50% of customers browse online before buying in store. Says expanding presence in New York City. Sees FY19 credit revenue growth in low to mid single-digit range. Sees FY19 adjusted EBITDA $805M-$855M. Comments and guidance taken from Q2 investor presentation slides.
|
SPRT | Hot Stocks16:41 EDT Julian Singer discloses 4.9% stake in Support.com, urges strategic alternatives - Julian Singer disclosed a 4.9% stake in Support.com, which represents 929.7K shares of common stock and allows for activism. The filing discloses that "the Reporting Persons have engaged, and plan to continue to engage, with the Issuer's management and board of directors regarding opportunities to unlock shareholder value. The Reporting Persons believe that the Issuer's recent grants of restricted stock units to Board members are excessive and without merit, and raise serious concerns as shares of Common Stock are trading significantly below their share price from one year ago, with the Issuer's enterprise value lower than the cash on its balance sheet. Given the $10 million monetary judgment that the Issuer agreed to pay to the Federal Trade Commission (the "FTC") earlier this year as part of a settlement to resolve the FTC's allegations of deceptive practices, and the loss of a substantial contract that the Issuer has yet to quantify, the Reporting Persons believe that the issuance of free stock is even more concerning. The Reporting Persons have questioned the Issuer's inaction with respect to a cash distribution to shareholders and believe that the Issuer did not provide adequate rationale for failing to do so. The Reporting Persons believe that the Issuer should evaluate potential strategic alternatives to maximize value, such as by exploring a sale process."
|
HTHT | Hot Stocks16:37 EDT Huazhu Group approves $750M share repurchase program - Huazhu's Board of Directors has approved a share repurchase program of up to $750M, effective for five years.
|
LB | Hot Stocks16:35 EDT L Brands reports Q2 Stores Only SSS down 4% - Reports Q2 Stores Only SSS for Victoria's Secret down 9% and for Bath & Body Works up 4%.
|
LB | Hot Stocks16:34 EDT L Brands reports Q2 Stores and Direct SSS down 1% - Reports Q2 SSS for Victoria's Secret down 6% and for Bath & Body Works up 8%.
|
BGNE | Hot Stocks16:33 EDT BeiGene announces FDA acceptance of zanubrutinib NDA to treat MCL patients - BeiGene announced that the FDA has accepted the company's new drug application, or NDA, for zanubrutinib for the treatment of patients with mantle cell lymphoma, or MCL, who have received at least one prior therapy. The FDA granted priority review for the NDA and has set a Prescription Drug User Fee Act, or PDUFA, target action date of February 27, 2020. This follows the FDA's breakthrough therapy designation for zanubrutinib in this setting earlier this year. The NDA data package includes data from the global Phase 1/2 trial in patients with B-cell lymphomas and an aggregate of 123 patients in the multicenter Phase 2 trial of zanubrutinib in patients with relapsed or refractory MCL in China as well as safety data on 641 patients from five clinical trials, and non-clinical data.
|
AMR | Hot Stocks16:32 EDT Alta Mesa Resources receives Nasdaq non-compliance notice - Alta Mesa Resources, Inc. announced that The NASDAQ Stock Market LLC notified the company on August 16, 2019 that it is not in compliance with NASDAQ Listing Rule 5250c1 for continued listing due to the delay in filing its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019. Previously, NASDAQ had granted the company an exception until September 30, 2019 to file its delinquent Annual Report on Form 10-K for the year ended December 31, 2018, its delinquent Quarterly Report on Form 10-Q for the period ended March 31, 2019 and its Quarterly Report on Form 10-Q for the period ended June 30, 2019. The company is required to submit an update to its original plan to regain compliance with NASDAQ Listing Rule 5250c1 for continued listing by September 3, 2019. Any additional exception to allow the company to regain compliance with all delinquent filings will be limited to September 30, 2019. The notice has no immediate effect on the listing of the company's Class A Common Stock on NASDAQ's exchange. The company intends to submit its curative plan to NASDAQ prior to September 3, 2019 and is working to complete the Quarterly and Annual Reports to regain compliance.
|
ESTC | Hot Stocks16:31 EDT Elastic acquires Perched, terms not disclosed - Elastic announced that it is joining forces with Perched, a training and consulting company focused on security analytics, threat hunting and security operations. The acquisition will give Elastic's users training and consulting services for building advanced cybersecurity solutions using the Elastic Stack, including practitioner-level expertise for deploying, managing, and operating Elastic SIEM and Elastic's proposed acquisition of Endgame. Financial terms were not disclosed. The transaction was completed in Elastic's fiscal Q2 2020 and is not expected to have a significant impact on Elastic's operating results.
|
SMPL | Hot Stocks16:29 EDT Simply Good Foods to acquire Quest Nutrition for $1B in cash - The Simply Good Foods Company and Quest Nutrition announced that the companies have entered into a definitive agreement under which Simply Good Foods will acquire Quest for $1.0B in cash, or approximately $870M net of tax benefits, on a cash-free and debt-free basis. The transaction is structured as the purchase by a subsidiary of Simply Good Foods of 100% of the equity of each of Voyage Holdings and VMG Quest Blocker from the founders of Quest and other equity holders of the target. Simply Good Foods intends to finance the transaction by using approximately $225M of cash on its balance sheet as well as committed financing from Barclays, Credit Suisse and Goldman Sachs. The company also anticipates issuing equity and, given the expected solid cash flow generation of the combined businesses, anticipates a net debt to adjusted EBITDA multiple of 4.0x or less by fiscal year-end August 2020. The transaction has been approved with unanimous support by the board of Simply Good Foods, its purchasing subsidiary and by the governing bodies of the target and is expected to close by the end of 2019, subject to satisfaction of customary closing conditions and receipt of regulatory clearance.
|
LPLA | Hot Stocks16:28 EDT LPL Financial says assets served at July-end up 1% compared to June-end - LPL Financial released its monthly activity report for July.Total brokerage and advisory assets served at the end of July were approximately $713B, a $7B increase, or 1.0%, compared to the end of June 2019. Total net new assets for July were an inflow of $2.7B. This included $0.5B of outflows related to a hybrid firm that set up its own broker/dealer and departed as discussed during the Company's Q1 2019 earnings call. Prior to these outflows, total net new assets for July were an inflow of $3.2B. Total client cash balances at the end of July were $29.9B, a $0.2B decrease compared to June 2019. Net buying in July was $3.3B.
|
XNCR | Hot Stocks16:25 EDT Xencor Chief Scientific Officer Desjarlais sells 35K shares of common stock - In a regulatory filing, Xencor disclosed that its Chief Scientific Officer John Desjarlais sold 35K shares of common stock on August 19th. The total transaction size was $1.42M.
|
MVBF | Hot Stocks16:24 EDT MVB Financial boosts quarterly dividend payout 25% over prior quarter payout - MVB Financial has declared a quarterly cash dividend of 5c per share payable on September 15, to shareholders of record at the close of business on September 1. This is the third quarterly dividend for 2019 and includes a 25% increase as compared to the previous quarter dividend payout. "At MVB, we have built a strong foundation allowing us to provide positive impact now and in the future for our shareholders, clients, communities and Teammates as our trusted partners. Our four lines of business - Commercial, Retail, Mortgage and Fintech - are firing on all cylinders. Over the past couple years, we have significantly increased our dividend payout as one more way we can create added value for our shareholders," said Larry F. Mazza, CEO and President, MVB Financial Corp.
|
SPLK | Hot Stocks16:19 EDT Splunk up over 6% at $136.26 per share after Q2 earnings beat, raised FY19 view
|
SEDG | Hot Stocks16:18 EDT SolarEdge CEO Guy Sella takes leave of absence, Zvi Lando named Acting CEO - SolarEdge's Co-Chairman, CEO and founder, Guy Sella's previously disclosed health condition has declined significantly. In that connection, he has taken a leave of absence, effective immediately, to address his health issues. Zvi Lando,has been appointed to serve as Acting CEO. Lando has been a part of the executive management team since 2009. He has served as EVP Global Sales since joining SolarEdge in 2009. Prior to joining SolarEdge, Lando held several different technology and management positions at Applied Materials, including in his last role, as Vice President and General Manager of Baccini Cell Systems Division in the Applied Materials Solar Business Group.
|
FTFT | Hot Stocks16:17 EDT Future FinTech receives letter from Nasdaq over Q2 report - Future FinTech Group announced that on August 20, 2019, the company received a notification letter from the NASDAQ Listing Qualifications stating the company was not in compliance with NASDAQ Listing Rule 5250c1, due to its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019. Previously, in a notification letter dated July 29, 2019, NASDAQ had granted the company an exception until August 31, 2019 to file its delinquent Form 10-K for the period ended December 31, 2018 and until September 30, 2019 to file the Forms 10-Q for the periods ended March 31 and June 30, 2019 based upon the initial plans of compliance submitted by the company to NASDAQ. As a result of this additional delinquency of Form 10-Q, the company is provided until September 3, 2019 to submit an update of the Initial Plans of Compliance to regain compliance with respect to the filing requirement.
|
PGRE | Hot Stocks16:17 EDT Paramount Group announces two acquisitions - Paramount Group announced that it has completed the acquisition of a 44% joint venture interest in 55 Second Street in San Francisco. The property was valued at approximately $402.0M, or $1,039 per square foot. In connection with the acquisition, the existing $137.5M mortgage loan will remain in place and be upsized by an additional $50.0M. The $187.5M mortgage loan is interest-only at a fixed interest rate of 3.88% and matures in October 2026. In an unrelated transaction, the company also announced that it has entered into an agreement to acquire Market Center, a two-building Class A office complex comprising 753,000 square feet, located in San Francisco's South Financial District. The purchase price is approximately $722.0M, or $959 per square foot. The transaction, which is subject to customary closing conditions, is expected to close in Q4. In connection with the transaction, the company expects to bring in a joint venture partner prior to closing.
|
SAIC | Hot Stocks16:16 EDT SAIC awarded $812M in contract to support U.S. security, intelligence activities - Science Applications International Corp. was awarded $812M in contracts to support various U.S. government national security and intelligence activities during late July. SAIC will provide services and solutions to customers with requirements for highly-specialized technical and operational expertise in technology integration, engineering, and IT modernization. These contract awards come just six months after SAIC's completed acquisition of Engility as part of a broader company strategy to expand its intelligence community portfolio.
|
CBU | Hot Stocks16:16 EDT Community Bank System raises quarterly dividend by 8% to 41c per share - The dividend will be payable on October 10, 2019 to shareholders of record as of September 16, 2019.
|
FGEN | Hot Stocks16:15 EDT FibroGen says roxadustat approved in China for anemia treatment in CKD patients - FibroGen announced that the National Medical Products Administration, NMPA, in China has approved expansion of the marketing authorization of roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor,HIF-PHI, for the treatment of patients with anemia caused by chronic kidney disease, CKD, to include treatment in CKD patients who are not dialysis-dependent, NDD. Marketing authorization for roxadustat for the treatment of anemia associated with CKD in patients who are dialysis-dependent, DD,was granted by the NMPA in December of 2018.
|
HP | Hot Stocks16:11 EDT Helmerich & Payne acquires DrillScan, terms not disclosed - Helmerich & Payne announced its wholly owned subsidiary, Helmerich & Payne Technologies, LLC, has acquired DrillScan, a provider of proprietary drilling engineering software, well engineering services and training for the oil and gas industry. DrillScan will operate as part of H&P Technologies, H&P's dedicated business entity focused on developing advanced technologies and directional drilling automation solutions to help customers achieve greater reliability involving wellbore quality, accuracy and performance. DrillScan brings a team of highly respected industry experts who will contribute to research, development and innovation efforts to advance H&P's digital technology portfolio. DrillScan will maintain its headquarters in France and its other international locations, including the United States. The terms of the DrillScan transaction were not disclosed.
|
SNPS | Hot Stocks16:10 EDT Synopsys CEO says company 'continues to execute very well' - "Synopsys continues to execute very well and delivered excellent third fiscal quarter revenue, operating margin, non-GAAP earnings and cash flow. In Q3, we also implemented a $100 million share repurchase, bringing our total for the year to $229 million," said Aart de Geus, chairman and co-CEO of Synopsys. "Despite the uncertain geopolitical and economic backdrop, global design activity and customer engagements are thriving. Our product platforms are the strongest they've ever been, driving technology wins and competitive displacements. As a result of our year-to-date overachievement and broad-based strength across the business, we're raising our annual guidance ranges."
|
PKI | Hot Stocks16:10 EDT PerkinElmer announces retirement of CEO Robert Friel; affirms FY19 view - PerkinElmer announced that after 12 years as CEO, Robert F. Friel, has decided to retire as chairman and CEO and member of the board of directors as of the end of the company's FY19. After December 29, Mr. Friel will continue as an advisor to the company until March 1, 2020. Prahlad Singh, president and chief operating officer, has been appointed CEO, effective December 30, 2019. Dr. Singh has also been elected as a director of the company, effective today. In addition, Alexis Michas, currently serving as lead director, has been elected to serve as non-executive chairman of the board of the company as of December 30, 2019. The Company also today reaffirmed its financial guidance provided in its July 29, 2019 press release.
|
OLED | Hot Stocks16:09 EDT Universal Display, EMT announces OLED host partnership - Universal Display Corporation and Eternal Material Technology Company announced a strategic OLED host partnership. The two companies have been working together to commercialize OLED host materials. With this partnership, Universal Display leads the R&D discovery and development work on red, green and yellow host materials to best complement its phosphorescent emitters. EMT will be a volume manufacturer and vendor of these host materials to certain Chinese panel manufacturers. Financial terms of the partnership agreement were not disclosed.
|
PSMT | Hot Stocks16:09 EDT PriceSmart to build new warehouse club in Colombia - PriceSmart announced that on August 21, it acquired approximately 111,000 square feet of land in Colombia upon which the company plans to construct its 47th warehouse club. This club will be located within the city of Bogota, Colombia. The 170th Street Bogota club is expected to open, approximately, in the fall of 2020.
|
ALSK | Hot Stocks16:09 EDT Alaska Communications commends FCC's Rural Health Care Order - Leonard Steinberg, Senior Vice President, Legal, Regulatory and Government Affairs at Alaska Communications commented that: "Technology and telemedicine have assumed an increasingly important role in health care delivery, particularly in rural and remote areas of Alaska and the country. Broadband plays a critical role in the delivery of telemedicine, giving patients in rural areas high-quality health care services. We thank the Commission for recognizing that its Rural Health Care program rules have been problematic, and taking steps to adopt new rules that are intended to clarify the program's funding. In particular, we appreciate that the Commission understood that Alaska is unique and created sub-tiers within the program that improve the likelihood that the benefits of this program will reach some of America's most remote locations. We also commend the Commission for providing greater clarity regarding the transition for multi-year contracts. We thank the Alaska Delegation for its continued support of the Rural Health Care program and the significant impact it has on the health and wellbeing of rural Alaskans."
|
SPLK | Hot Stocks16:04 EDT Splunk reports Q2 annualized recurring revenue over $300M - "With year-over-year revenue growth of 80% and ARR now over $300 million, the strength of our cloud business is driving a faster transition to a renewable software model," said Jason Child, CFO, Splunk. "By the end of the year, we expect that virtually all new software sales will be cloud or term license-based."
|
INCY | Hot Stocks16:02 EDT Incyte's pemigatinib granted FDA orphan designation - Incyte's pemigatinib was granted FDA orphan designation as a treatment of myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2, according to a post to the agency's website. Reference Link
|
SPLK | Hot Stocks16:02 EDT Splunk to acquire SignalFx for roughly $1.05B - Splunk announced a definitive agreement to acquire SignalFx, a SaaS player in real-time monitoring and metrics for cloud infrastructure, microservices and applications. Under the terms of the agreement, Splunk will acquire SignalFx for a total purchase price of approximately $1.05B, subject to adjustment, to be paid approximately 60% in cash and 40% in Splunk common stock. The acquisition is expected to close in the second half of fiscal 2020, subject to customary closing conditions and regulatory reviews. "The strength of our balance sheet allows us to pay the majority of purchase price consideration with cash on hand. Total equity consideration plus initial SignalFx employee retention incentives will result in less than three percent total dilution from this transaction," said Jason Child, chief financial officer, Splunk. "Post-closing, we expect to absorb the acquired operational expenses of SignalFx within our existing plan. At this time, we are reaffirming our full year non-GAAP operating margin target," he continued.
|
LSCC | Hot Stocks16:02 EDT Lattice Semiconductor awarded NEW H3C contract - Lattice Semiconductor announced that NEW H3C has selected the Lattice MachXO3 FPGA to provide system control logic and I/O extension capabilities for the latest NEW H3C server platform. Lattice MachXO3 FPGAs simplify deployment of control applications in systems by integrating power and I/O management with security features and programmable flash memory on a single device. NEW H3C uses the MachXO3 FPGA on their single, dual, quadruple and 8-socket CPU boards for server, storage, and networking systems.
|
SMPL | Hot Stocks16:00 EDT Simply Good Foods trading halted, news pending
|
ZAGG | Hot Stocks15:54 EDT Zagg up 16% after NY Post report on interest from multiple possible buyers
|
TSE | Hot Stocks15:39 EDT Trinseo raises prices for latex technologies in North America - Trinseo announced that effective September 16, 2019, the company is increasing the prices of all Styrene Butadiene and Styrene Acrylate products sold into the carpet, paper, and paperboard markets in North America. The increase will be 6c/dry lb. for all indexed and non-indexed customers, as contracts allow. This increase is necessary due to changes in market conditions and to offset rising costs to manufacture and transport our products, and to remain a strong and reliable supplier.
|
ADTN | Hot Stocks15:38 EDT Adtran receives non-compliance notification from Nasdaq - Adtran announced that it received a standard notification letter from The Nasdaq Stock Market LLC, dated August 15, 2019, stating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended June 30, 2019, Adtran is not in compliance with Nasdaq Listing Rule 5250c1, which requires timely filing of periodic financial reports with the Securities and Exchange Commission. This notice has no immediate effect on the listing of Adtran's common stock on the Nasdaq Global Select Market. Nasdaq's listing rules provide the company with 60 calendar days from the date of the notice to submit a plan to regain compliance. The company expects to file the Form 10-Q within this 60 calendar day period, eliminating the need for the company to submit a formal plan to regain compliance.
|
VSTO | Hot Stocks15:36 EDT Vista Outdoor CFO Lopez acquires 10,000 common shares - In a regulatory filing, Vista Outdoor SVP and CFO Miguel A. Lopez disclosed the purchase of 10,000 common shares of the company at a price of $4.81 per share.
|
GILD | Hot Stocks14:41 EDT Gilead says submitted petitions to USPTO requesting review of HHS patents - Gilead announced that it has submitted petitions to the U.S. Patent and Trademark Office requesting an inter partes review of patents granted to the U.S. Department of Health and Human Services for HIV pre-exposure prophylaxis and post-exposure prophylaxis. An inter partes review re-examines the claims in a patent to determine whether they are valid. The company stated: "We strongly believe that the patents granted to HHS since 2015 for PrEP and PEP are not valid. Published materials clearly show that well before HHS claims to have invented the concepts of PrEP and PEP in 2006, others had conceived of using an antiretroviral therapy, including Truvada, for both forms of prophylaxis. For example, guidelines published in 2004 recommended administering combination antiretrovirals - including Truvada - to certain categories of 'high risk' individuals before an HIV exposure, while the Center for Disease Control and Prevention's own 2005 guidelines recommended Truvada for prophylaxis immediately after exposure. The ongoing dialogue about these patents is a distraction from the important work being done by Gilead and its many community partners to reduce barriers to PrEP. Resolving the patent issues will refocus the public dialogue about PrEP on what matters most: the real-world obstacles that prevent people at risk for HIV from accessing effective prevention. Those with the greatest need for PrEP face significant social and structural barriers, such as limited access to affordable healthcare, low awareness of PrEP, stigma, discrimination, and insurance benefit design that places a significant cost-sharing burden on patients. Gilead remains committed to increasing access to PrEP for everyone in need and we will continue to invest in a wide range of programs to help accelerate access and awareness."
|
AEP | Hot Stocks14:36 EDT American Electric seeks proposals for several coal types - American Electric Power issued a request for proposal for the supply of coal to one or more of its generating stations in multiple coal regions. AEP seeks proposals for the following coal type and delivery years: Central Appalachian Basin in 1Q20; Powder River Basin in 4Q19, 1Q10, CY21, and CY22; Illinois Basin in CY21 and CY22; and Northern Appalachian Basin in CY20, CY21, and CY22. All coal proposal packages should include the provided coal proposal form included in the RFP. This information must be received no later than 5 p.m., Wednesday, September 4, 2019. Proposals are to be kept open until 5 p.m., Tuesday, September 17, 2019.
|
APU UGI | Hot Stocks14:32 EDT AmeriGas unitholders approve merger with UGI Corporation - UGI Corporation (UGI) and AmeriGas Partners ( APU) announced that the Partnership's common unitholders voted to approve the merger agreement, by and among UGI, AmeriGas Propane, the general partner of the Partnership, AmeriGas Propane Holdings, an indirect, wholly owned subsidiary of UGI, AmeriGas Propane Holdings, an indirect, wholly owned subsidiary of UGI, and the Partnership, and the transactions contemplated thereby, including the merger of merger sub with and into the Partnership, with the Partnership surviving as an indirect, wholly owned subsidiary of UGI.
|
WYND | Hot Stocks14:11 EDT Wyndham Destinations to add 140 jobs in Orlando expansion - Wyndham Destinations announced it would add 140 jobs to its South Orlando call center operations as part of an expansion to support the ongoing growth of its vacation club business. The company is nearly doubling the size of its leased offices at 8403 South Park Circle to 42,000 square feet, expanding into space previously occupied by other hospitality companies. It is investing $4.5M to upgrade office spaces, add new furniture and invest in technology to provide a comfortable, modern workspace for its growing workforce. There are currently 40 marketing executive positions open at the call center, with an additional 100 jobs to be filled during the first quarter of 2020. Construction of the new office space will be completed in April 2020.
|
VLKAY POAHY | Hot Stocks14:03 EDT Porsche acquires minority stake in Israeli startup TriEye - Volkswagen's (VLKAY) Porsche (POAHY) announced that it has acquired a minority stake in Israeli start-up TriEye. The newly established company has developed a sensor technology for short-wave infrared. It enhances safety in vehicles fitted with assistance systems or autonomous driving functions by improving the ability to see in weather conditions where visibility is poor, such as dust, fog, murky conditions or rain, Porsche said. The company's unique semi-conductor design uses patent-pending technology that makes it possible to manufacture SWIR HD cameras at a fraction of their current cost, the car maker added.
|
PFE | Hot Stocks14:01 EDT Pfizer says FDA grants XTANDI application priority review - Astellas Pharma and Pfizer announced that the U.S. Food and Drug Administration has accepted for review the filing of a supplemental New Drug Application for XTANDI to add an indication for the treatment of men with metastatic hormone-sensitive prostate cancer. The application has also been granted Priority Review, a designation given to those applications for drugs that, if approved, may offer significant improvements in the safety or effectiveness of the treatment, diagnosis or prevention of serious conditions when compared to standard applications. XTANDI is currently indicated in the U.S. for the treatment of patients with castration-resistant prostate cancer. The submission is based on results from the Phase 3 ARCHES trial presented at the 2019 Genitourinary Cancers Symposium in February and published in The Journal of Clinical Oncology in July 2019. The study evaluated the efficacy and safety of XTANDI plus androgen deprivation therapy versus ADT plus placebo in men with mHSPC. The primary endpoint of radiographic progression-free survival was met in the study.
|
CBL | Hot Stocks13:32 EDT CBL Properties to pursue measures to cure NYSE rule non-compliance - CBL Properties announced that it received notification from the New York Stock Exchange that as of August 19, 2019, the company is no longer in compliance with NYSE continued listing criteria, which require listed companies to maintain an average closing share price of at least $1.00 over a consecutive 30 trading-day period. The company said it intends to pursue measures to cure the share price non-compliance, including through a reverse stock split of the company's common stock, subject to stockholder approval, no later than at its next annual meeting of stockholders, if such action is necessary to cure the share price non-compliance. In accordance with NYSE rules, the company has a period of six months from receipt of the notice to regain compliance with the NYSE's minimum share price requirement, or until the company's next annual meeting of stockholders, if stockholder approval is required to cure the share price non-compliance, as would be the case to effectuate a reverse stock split.
|
GOOG GOOGL | Hot Stocks13:16 EDT YouTube Premium users can now listen directly within Waze app - In an earlier blog post, YouTube said, "Drivers, rejoice! Never worry again about switching between YouTube Music (to listen) and Waze (to navigate). Rolling out today, YouTube Premium and Music Premium subscribers can safely listen to their favorite music from directly within the Waze app, where they get their directions. All of the albums, playlists, personalized mixes, and more that fans love to listen to are now available with a couple of quick taps as they navigate to where they need to go. With YouTube Music and Waze together in one experience, there has never been a more entertaining way to get around." Reference Link
|
BHC | Hot Stocks13:06 EDT Bausch Health trades up after VP Humphries buys over $650K in shares - Bausch Health VP William Humphries disclosed in a filing that he had purchased 30,703 shares of company stock at an average price of $ $21.18 per share on August 16. The total transaction value of the purchase was $$650,142. Bausch Health is up almost 5% or $1.00 per share in afternoon trading on Wednesday to $22.26 per share.
|
IGLD | Hot Stocks12:16 EDT Internet Gold announces receipt of Nasdaq non-compliance notice - Internet Gold announced that on August 19 it received a notice from the Listing Qualifications Department of Nasdaq advising the company that it was not in compliance with a listing rule requiring companies on The Nasdaq Global Select Market to maintain a minimum of 750,000 publicly held shares. The company said it has a 45 days period, until October 3, 2019, to submit a plan to regain compliance. If the plan is accepted, the company may be granted an extension of up to 180 calendar days to regain compliance with this particular rule, the company noted.
|
GE | Hot Stocks12:16 EDT NY AG files lawsuit against EPA over GE Hudson River PCB cleanup - New York Attorney General Letitia James and Governor Andrew M. Cuomo filed a lawsuit against the U.S. Environmental Protection Agency for violating federal law when it issued a "Certificate of Completion" to General Electric Company for its removal of polychlorinated biphenyls from the Hudson River. The EPA issued the certificate to GE on April 11, 2019, finding that the company's required cleanup of PCBs from the river was complete, despite evidence that concentrations remain dangerously high in portions of the river. On the day the EPA issued the Certificate of Completion, the EPA's Five-Year Review found that the cleanup was not adequately protective of human health and the environment. The EPA concluded that the Agency does not have sufficient information to even determine if or when the cleanup would meet this standard. For this and other reasons, the lawsuit charges that the EPA's issuance of the Certificate of Completion to GE is beyond the Agency's legal authority and should be vacated. "We will not allow the EPA to let big polluters like General Electric off the hook without a fight," said Attorney General James. "The facts are clear: Hudson River fish remain much too contaminated with PCBs to safely eat, and EPA admits they don't know when - or if - they ever will be. EPA can't ignore these facts - or the law - and simply pronounce GE's cleanup of PCBs complete. That is why we filed this lawsuit to force EPA to follow the law and require GE to truly complete its PCB cleanup and finally return the full use of the Hudson River to the people of New York." Reference Link
|
IGLD | Hot Stocks12:14 EDT Tel Aviv court approves s petition to approve arrangement on Searchlight pact - Earlier on Wednesday, Internet Gold - Golden Lines announces that Tel Aviv-Jaffa District Court has approved the company's petition to approve the arrangement regarding the Searchlight Transaction pursuant to section 350 of the Israeli Companies Law. The Petition was submitted to the Tel Aviv-Jaffa District Court on August 8 following the unanimous approval of the Arrangement by the meeting of the company's creditors held on July 30 and the approval by the meeting of the company's shareholders held on August 8. The meetings were convened in accordance with the Israeli court's decision, as previously announced by the company.
|
RTN | Hot Stocks12:08 EDT Raytheon to deliver additional wireless TOW missiles to US Army - Raytheon will deliver additional tube-launched, optically tracked, wireless-guided missiles for the TOW weapon system under a $101M U.S. Army contract announced by the U.S. Department of Defense on May 10. The weapon system transitioned to wireless guidance in 2010 and is being produced for the Army, U.S. Marines and international customers.
|
CMCM | Hot Stocks12:00 EDT Cheetah Mobile falls -8.4% - Cheetah Mobile is down -8.4%, or -38c to $4.13.
|
JMIA | Hot Stocks12:00 EDT Jumia Technologies falls -12.5% - Jumia Technologies is down -12.5%, or -$1.84 to $12.91.
|
MSGN | Hot Stocks12:00 EDT MSG Networks falls -12.8% - MSG Networks is down -12.8%, or -$2.15 to $14.70.
|
NM | Hot Stocks12:00 EDT Navios Maritime rises 13.7% - Navios Maritime is up 13.7%, or 75c to $6.22.
|
EBR | Hot Stocks12:00 EDT Centrais Electricas rises 14.3% - Centrais Electricas is up 14.3%, or $1.41 to $11.24.
|
TGT | Hot Stocks12:00 EDT Target rises 19.4% - Target is up 19.4%, or $16.62 to $102.15.
|
JMIA | Hot Stocks11:54 EDT Jumia CEO says review started 'completely independently' of Citron allegations - Jumia Technologies CEO Sacha Poignonnec is being interviewed on CNBC. Jumia Technologies disclosed earlier that it received information alleging that some of its independent sales consultants, members of its JForce program in Nigeria, may have engaged in improper sales practices. In response, the company launched a review of sales practices covering all countries of operation and data from January 1, 2017 to June 30. In the course of this review, the company identified several JForce agents and sellers who collaborated with employees in order to benefit from differences between commissions charged to sellers and higher commissions paid to JForce agents. Jumia said it terminated the employees and JForce agents involved, removed the sellers implicated and implemented measures designed to prevent similar instances in the future. "The review of this matter is closed. More recently, the company also identified instances where improper orders were placed, including through the JForce program, and subsequently cancelled," the company noted earlier this morning.
|
TOL | Hot Stocks11:27 EDT Toll Brothers sees community count growth in 2020
|
TOL | Hot Stocks11:24 EDT Toll Brothers says demand in August 'off to a good start'
|
TOL | Hot Stocks11:13 EDT Toll Brothers sees 'modest' growth in community count in Q4
|
TOL | Hot Stocks11:07 EDT Toll Brothers says decreased incentives slightly in Q3 vs. Q2 - Comments taken from Q3 earnings conference call.
|
TOPS | Hot Stocks11:02 EDT TOP Ships announces 1-for-20 reverse stock split - TOP Ships announced that it has determined to effect a 1-for-20 reverse stock split of the company's issued common shares. The company's shareholders approved the reverse stock split and granted the board the authority to determine the exact split ratio and when to proceed with the reverse stock split at the company's Annual Meeting of Shareholders held on August 7. The reverse stock split will take effect, and the company's common stock will begin trading on a split-adjusted basis on the NASDAQ Capital Market, as of the opening of trading on Thursday, August 22, under the existing ticker symbol "TOPS." When the reverse stock split becomes effective, every 20 shares of the company's issued and outstanding common stock will be automatically combined into one issued and outstanding share of common stock without any change in the par value per share or the total number of authorized shares. This will reduce the number of outstanding shares of the company's common stock from approximately 31.7M shares to approximately 1.6M shares. No fractional shares will be issued in connection with the reverse split of the issued and outstanding common stock. Shareholders shall be paid cash-in-lieu of a fractional shares that occur as a result of the reverse stock split.
|
BLL | Hot Stocks11:01 EDT Ball Corp. to sell tinplate steel aerosol packaging facilities in Argentina - Ball Corporation announced an agreement to sell its tinplate steel aerosol packaging facilities in Garin and San Luis, Argentina, to Envases del Plata S.A., an Argentinian metal packaging company. The transaction is expected to close later this year and we expect the business will continue to be operated consistent with its successful long-term performance. Financial terms have not been disclosed. Post-close, Ball said in a statement that it will continue to serve the growing demand for sustainable aluminum aerosol containers and aluminum slugs around the world from its eight facilities located in Canada, Czech Republic, France, India, Mexico, the United Kingdom and the United States. Ball's global aluminum aerosol business will continue to be led by Stan Platek, vice president and general manager.
|
HSGX | Hot Stocks10:14 EDT Histogenics merger partner Ocugen granted FDA orphan designation - Ocugen's treatment of CEP290 mutation associated retinal disease was granted orphan designation by the FDA, according to a post to the agency's website. On April 8, Histogenics and Ocugen jointly announced that they had entered into a definitive merger agreement under which the stockholders of Ocugen will become the majority owners of Histogenics' outstanding common stock upon the close of the merger. Reference Link
|
PFE | Hot Stocks10:03 EDT Pfizer announces additional half billion dollar investment for Sanford facility - Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility is anticipated to support Pfizer's continuing investment in gene therapy research and development, similar to Pfizer's Chapel Hill and Kit Creek, North Carolina research and development sites. This facility would expand the company's presence in North Carolina, where there are currently more than 3,600 Pfizer colleagues, including 650 in Sanford. The expanded facility is projected to add approximately 300 new jobs. In addition to its gene therapy operations, colleagues at Pfizer's Sanford facility also manufacture components for the company's vaccine portfolio, including Prevnar 13 and several vaccines currently in Pfizer's research pipeline. "This investment will further strengthen Pfizer's leadership in gene therapy manufacturing technology," said Mike McDermott, President, Pfizer Global Supply. "The expansion of the Sanford site is expected to create hundreds of highly skilled jobs, which would increase Sanford's high-tech manufacturing environment and is part of our overall plan to invest approximately $5B in U.S.-based capital projects over the next several years."
|
LKSD | Hot Stocks10:03 EDT UBM acquires commingle operations from LSC Communications for $11.25M in cash - LSC Communications and United Business Mail announced that UBM has acquired LSC's commingle business for $11.25M in cash. The transaction includes LSC's commingle facility located in Aurora, Illinois, which LSC acquired as part of the acquisition of RRD Print Logistics in July of 2018. As part of the agreement, LSC Communications will continue to be the exclusive logistics services provider for all of UBM's mail.
|
LOW | Hot Stocks10:00 EDT Lowe's says seeing increased Pro customer service scores - Says: Has laundry list of improvements on tap to serve the Pro customer... Plans to repurchase $4B of shares in 2019... Underlying macro-economic picture in U.S. remains positive... Still in early days of company transformation... Will be more event-based, targeted with promotions... Does not expect much movement in inventory levels this year.
|
UVXY | Hot Stocks09:47 EDT ProShares Trust Ultra VIX Short Term Futures ETF falls -6.7% - ProShares Trust Ultra VIX Short Term Futures ETF is down -6.7%, or -$2.12 to $29.38.
|
MSGN | Hot Stocks09:47 EDT MSG Networks falls -6.8% - MSG Networks is down -6.8%, or -$1.14 to $15.71.
|
JMIA | Hot Stocks09:47 EDT Jumia Technologies falls -17.8% - Jumia Technologies is down -17.8%, or -$2.63 to $12.12.
|
GSX | Hot Stocks09:47 EDT GSX Techedu rises 6.9% - GSX Techedu is up 6.9%, or $1.01 to $15.66.
|
LOW | Hot Stocks09:47 EDT Lowe's rises 12.0% - Lowe's is up 12.0%, or $11.76 to $109.63.
|
TGT | Hot Stocks09:47 EDT Target rises 15.2% - Target is up 15.2%, or $13.04 to $98.57.
|
WKHS GM | Hot Stocks09:46 EDT Workhorse Group up 9% in early trading - Shares of Workhorse Group (WKHS) are up 34c, or 9%, to $3.98 in early trading. Traders are pointing to a website posting, which has since been pulled, at the URL "http://lordstownmotors.com" as driving speculation that the company has reached a deal with General Motors (GM) regarding the Lordstown plant, according to contacts.
|
PAVM | Hot Stocks09:33 EDT PAVmed announces issuance of U.S. patent - PAVmed announced that the U.S. Patent and Trademark Office has issued U.S. Patent 10,335,189 which covers the technology underlying PAVmed's CarpX minimally invasive device developed to treat carpal tunnel syndrome. The patent, assigned to PAVmed at its founding, lists Lishan Aklog, M.D., PAVmed's Chairman & CEO, and Brian J. deGuzman, M.D., its Chief Medical Officer, as inventors. Aklog stated: "We believe this patent creates significant barriers to entry for current and future competitors in the minimally invasive and percutaneous carpal tunnel release space, and will provide us with the commercial freedom to operate as we pursue the billion-dollar U.S. market opportunity that CarpX represents. It anchors PAVmed's robust and expanding intellectual property portfolio, which includes over 75 patents and patent applications across 10 families."
|
RECN | Hot Stocks09:32 EDT RGP sell assets of local Nordics business to Capacent - Resources Connection announced that its wholly-owned subsidiary, Resources Global Professionals Sweden has signed a definitive agreement with Capacent Holding. RGP Sweden will transfer substantially all of its employees, assets, liabilities, contracts and local client relationships in Sweden, Norway, Iceland and Denmark to Capacent in a cash transaction expected to close in September 2019. RGP will continue to serve its strategic global clients doing business in the Nordics.
|
PRSP | Hot Stocks09:27 EDT Perspecta awarded $1M DARPA to provide AI compact hardware research - Perspecta's applied research arm, Perspecta Labs, was awarded a prime contract from the U.S. Defense Advanced Research Projects Agency - DARPA - to provide Photonic Edge AI Compact Hardware research under DARPA's Artificial Intelligence Exploration program. The contract, which represents new work for the company, has a total value of $1M and work will be performed over 18 months. The goal of the PEACH program is to research and develop novel AI processing architectures in combination with innovative photonic hardware to enable breakthrough AI functionality with significant reduction in hardware complexity, latency and power consumption. The Perspecta Labs solution is aimed at high-accuracy and real-time machine learning from radio frequency data to provide major advances in AI capability for tactical DoD systems.
|
ASGN... | Hot Stocks09:17 EDT ASGN segment named Google cloud platform premier partner - ECS, a segment of ASGN (ASGN), has been named a premier partner for Google (GOOG) cloud platform for the second year in a row. ECS uses the Google cloud platform to solve customers' challenges and achieve cloud transformations.
|
LOW | Hot Stocks09:16 EDT Lowe's says average ticket grew 2% in Q2 - Says: Pro sales significantly outpaced DIY in Q2... Taking aggressive steps to improve technology platform... Expects sequential gross margin improvement in Q3, Q4... Plans to deploy new price management system by end of year. Comments taken from Q2 earnings conference call.
|
FIT | Hot Stocks09:11 EDT Fitbit announces collaboration with Singapore's Health Promotion Board - Fitbit announced that it will be collaborating with Singapore's Health Promotion Board, or HPB, on a healthy population project in support of Singapore's Smart Nation initiative. The HPB is Singapore's government agency that implements policy and programs to improve the nation's health. This is Fitbit's first major integration of a digital health platform and wearables into a national public health program globally. The initiative, named Live Healthy SG, was designed for Singapore by Fitbit and the HPB to harness technology, behavior insights and analytics to help Singaporeans get healthier through behavior change. Live Healthy SG will engage people of all ages and levels of health using Fitbit devices and its new premium service, which is launching to consumers in select markets around the world this fall. Live Healthy SG builds on Singapore's Smart Nation efforts to transform key sectors of society, including healthcare, through innovative technology. Fitbit was identified through a competitive call for collaboration and various levels of competitive evaluation. The initiative takes on the challenge of using its technology to help improve population health, based on the company's ability to drive behavior change and health outcomes. Live Healthy SG will leverage the full Fitbit ecosystem of wearable devices, software and services, including programs, guidance and individual 1:1 health coaching that will be offered through its new premium service. Singaporeans will be able to pre-register for Live Healthy SG starting mid-September, and the program will officially go live in late October. Participants who enroll in and commit to one year of Fitbit premium service will receive a Fitbit Inspire HR at no cost. In addition to driving positive lifestyle changes in individuals, the program will serve as a resource that provides population insights to inform future health programs.
|
AMZN | Hot Stocks09:10 EDT Amazon expands Portland Tech Hub, plans to create 400 new tech jobs - Amazon announced an expansion of its Portland Tech Hub and plans to create 400 new high tech jobs in fields including software development, operations, IT, Support Engineering, Solutions Architects, and Product Management. With a new 84,000 square foot office in downtown Portland Amazon expects to double its tech workforce in the area. The company has created more than 3,500 full-time jobs in Oregon since 2010 and invested over $9B in the state, including customer fulfillment facilities, cloud infrastructure, and compensation to its employees.
|
FICO | Hot Stocks09:10 EDT Fair Isaac CTO Stuart Wells resigns, Claus Moldt succeeds - FICO Executive VP and CTO Stuart Wells has resigned from the company for personal reasons. Claus Moldt, FICO's Chief Information Officer, has been promoted to Wells' post, effective immediately. Wells will remain with the firm in an advisory role through the end of the year to ensure a smooth transition. Prior to joining FICO in 2016, Moldt was CEO of mPath, an enterprise-scale rapid mobile application development platform built from the ground up on Amazon Web Services.
|
SIRI | Hot Stocks09:07 EDT Sirius XM announces new streaming subscription offer for college students - SiriusXM announced a new subscription package built for college students. The "Student Premier" package gives college students all the content in SiriusXM's "Premier Streaming" package for $4 per month, a 69% discount off the regular price of Premier Streaming of $12.99 per month. This new Student Premier Package gives subscribers streaming access to content outside their car, on a phone or tablet, at home on connected devices, and online.
|
ORI | Hot Stocks09:07 EDT Old Republic announces changes in senior executive ranks - Old Republic announced several changes in its senior executive ranks effective October 1. Current CEO and President of the Old Republic Risk Management Underwriting Division, Stephen Oberst, will become ORI's Executive VP and join its senior policy-making Office of the CEO. Terri Minik will succeed Stephen Oberst as President of Old Republic Risk Management, retaining her position as CEO. Minik has 27 years of experience in insurance and risk management, the past 9 with the company. Todd Gray, Senior VP and Treasurer, has also been named to the company's Office of the CEO. This follows on the heels of the company's May 9th announcement when it was reported that Craig Smiddy, ORI's President and COO, would become the company's President and CEO effective October 1.
|
CMI | Hot Stocks09:06 EDT Cummins COO Rich Freeland to retire, Tony Satterthwaite to succeed - Cummins announced that President and COO, Rich Freeland will retire after 40 years of service with Cummins. Freeland joined Cummins in 1979 as a second shift foreman in the Parts Distribution Center in Columbus, Indiana, the day after his graduation from Purdue University. Tony Satterthwaite, currently the distribution business president that employs approximately 16,000 people worldwide, will succeed Freeland as president and COO of Cummins. Satterthwaite joined Cummins in 1988 and has held leadership positions throughout the company's businesses and operations. Components president Tracy Embree will succeed Satterthwaite as distribution business president. Chief technical officer, or CTO, Jennifer Rumsey will succeed Embree as components business president. Jim Fier will succeed Rumsey as CTO. Fier has been with Cummins for more than 30 years and is a highly accomplished engineering leader. In engine development, Fier is recognized as one of the most technically skilled and experienced engineers in the industry.
|
ORI | Hot Stocks09:04 EDT Old Republic declares special one-time cash dividend of $1.00 per share - Old Republic's Board of Directors evaluated the overall level and liquidity of the company's capitalization and in anticipation of gradually reducing, with regulatory approval, the capitalization of ORI's run-off mortgage guaranty insurance subsidiaries, concluded that excess capital can now be returned to all shareholders in the form of a special, one-time cash dividend of $1.00 per common share to be paid to shareholders of record on September 6 concurrently with the regular cash dividend, for a total of $1.20 per share. Old Republic also declares regular quarterly cash dividend of 20c per common share. This dividend is payable September 16 to shareholders of record on September 6.
|
TGT... | Hot Stocks09:03 EDT Fly Intel: Pre-market Movers - UP AFTER EARNINGS: Target (TGT), up 17%... Lowe's (LOW), up 13%... Pinduoduo (PDD), up 14%. ALSO HIGHER: Kinder Morgan (KMI), up 3% after agreeing to sell the U.S. portion of the Cochin Pipeline to Pembina Pipeline (PBA) for $1.55B... Wanda Sports (WSG), up 8% after analysts at Morgan Stanley, Citi and Deutsche Bank started coverage of the stock with Buy or equivalent ratings... On Deck Capital (ONDK), up 8% after Morgan Stanley analyst James Faucette upgraded shares to Equal Weight with his price target lowered to $3.50 from $4. The analyst notes that after a 57% decline in the stock since the end of January, valuation is "more evenly" balancing its faster earnings growth with its relatively higher risk of incremental downward revisions. DOWN AFTER EARNINGS: Children's Place (PLCE), down 7%... Baozun (BZUN), down 6%... Cree (CREE), down 4%... Jumia Technologies (JMIA), down 19%. ALSO LOWER: Hawaiian Holdings (HA), down 4% after Stifel analyst Joesph DeNardi double downgraded shares to Sell from Buy and cut its price target to $20 from $30. DeNardi sees downside to 2020 consensus earnings estimates due to declining PRASM results starting in 2020 and Southwest's (LUV) announced additional capacity to Hawaii, which will likely lead to further market share losses.
|
TPCO | Hot Stocks09:03 EDT Tribune Publishing appoints Randy Novak as VP, national sales - Tribune Publishing Company announced Randy Novak has been named VP of National Sales. Novak has held numerous executive sales roles, most recently as VP, Business Development at NSA Media, where he oversaw all aspects of business growth and marketing.
|
TGT | Hot Stocks08:54 EDT Target says tariff impacts more of 'a 2020 issue' - Target management says impacts of tariffs are more of "a 2020 issue" and impacts will start to be realized in Q1.
|
PRGO ENDP | Hot Stocks08:45 EDT Perrigo and Endo reach settlement on Nascobal nasal spray patent litigation - Perrigo (PRGO) has settled its Hatch-Waxman litigation relating to Nascobal Nasal Spray brought by Endo (ENDP). Terms of the settlement are confidential. Annual market sales for the 12-months ending June were $90M.
|
TGT | Hot Stocks08:43 EDT Target sees SSS increases in Q3, Q4
|
APTX | Hot Stocks08:38 EDT Aptinyx presents preclinical data on NMDA receptor modulator NYX-458 - Aptinyx announced the presentation of preclinical data on its novel NMDA receptor modulator, NYX-458. The product candidate demonstrated positive recovery of performance on affective and spatial learning tasks that was impaired in a preclinical model of repeat closed head injury. In biomarker readings, NYX-458 also restored neuroendocrine function following disruption due to repeat closed head injury. The presented studies evaluated the effects of NYX-458 in a repeat closed head injury preclinical model. The cognitive and emotional deficits observed in the model are reflective of those observed in humans that have experienced repeated traumatic brain injury. In addition to evaluating behavioral effects, this model enables the evaluation of biomarkers, including protein and hormone changes, also associated with head injury. To evaluate the behavioral effects of NYX-458, two different models were used to observe performance on both spatial and affective learning tasks in rodents. In both models, Y-Maze and Positive Emotional Learning, performance was significantly impaired following repeat closed head injury. Administration of NYX-458 resulted in performance on both of these cognitive tasks that was statistically significantly better than performance following administration of vehicle. The presented data show that repeat closed head injury resulted in activation of glial fibrillary acidic proteins; mirroring data found in other traumatic brain injury models. Closed head injury also resulted in transient decreases in GluN2A and GluN2B subunits of the NMDA receptor. NYX-458, which has been shown preclinically to positively modulate NMDA receptors, may be well suited to address this observed NMDA receptor hypofunction, warranting further preclinical and clinical evaluation. Neuroendocrine changes, including reduced growth hormone and increased corticosterone levels, were also observed following repeat closed head injury. In the model presented, NYX-458 administration restored normal levels of corticosterone and growth hormone. Overall, the presented cognitive behavioral and biomarker data further support the evaluation of NYX-458 in human clinical studies in cognitive impairment. The results indicate the potential utility of NYX-458 in addressing both the cognitive impairment and the underlying disease processes associated with repeated traumatic brain injury and other neurodegenerative conditions.
|
NEWT | Hot Stocks08:37 EDT Newtek Business Services raises quarterly dividend to 58c per share - Newtek Business Services announced that its Board of Directors declared a third quarter 2019 cash dividend of 58c per share, which represents a 20.8% increase over the third quarter 2018 cash dividend. The third quarter 2019 dividend is payable on September 30, 2019 to shareholders of record as of September 20, 2019. The Company also raised its 2019 annual cash dividend forecast to $2.151 per share, which would represent a 19.4% increase over the Company's 2018 annual dividend payment of $1.80 per share.
|
GNLN | Hot Stocks08:36 EDT Greenlane announces exclusive U.S. distribution partnership with Cookies - Greenlane announced a partnership with Cookies for the launch and exclusive U.S. distribution of the Cookies hemp-derived CBD product line, including Cookies CBD cartridges for the G Pen Gio. Cookies CBD products will feature terpene profiles inspired by famous Cookies strains, such as Cereal Milk, London Pound Cake 75 and Gelatti. Expected to launch in Q4 Greenlane will leverage its North American distribution network of more than 11,000 retail locations, including licensed cannabis dispensaries, and smoke and vape shops, to make Cookies' CBD products available to consumers across the U.S.
|
SEED | Hot Stocks08:35 EDT Origin Agritech regains full compliance with Nasdaq listing rules - Origin Agritech has regained full compliance with NASDAQ listing rules. On June 5, the company was notified by NASDAQ that it was not in compliance with the NASDAQ listing rules regarding the minimal requirements for stockholders' equity. Since September 30, 2018, the company increased its stockholder's equity mainly through an equity financing in January 2019. The company also applied to change from the NASDAQ Global Select Market to the NASDAQ Capital Market, the application for which was approved and trading on NASDAQ Capital Market for the ordinary shares of the company commenced August 19.
|
VST | Hot Stocks08:33 EDT Vistra Energy to close four Illinois power plants - Vistra Energy and its subsidiaries announced the four power plants that will retire in order to meet the requirements of the recently approved revisions to the Multi-Pollutant Standard rule imposed by the Illinois Pollution Control Board. Without this rule change, the company's entire downstate fleet was at risk of near imminent retirement. The company will close the following four coal-fueled power plants in Illinois: Coffeen Power Plant, Duck Creek Power Plant in Canton, Havana Power Plant, and Hennepin Power Plant. These plant retirements are required by the revised MPS rule, which regulates emissions at eight power plants operated by Vistra subsidiaries. Approximately 300 jobs will be eliminated across the four plant sites. Vistra is providing outplacement services and working with state workforce agencies to assist the employees impacted by the closures.
|
SAR | Hot Stocks08:33 EDT Saratoga Investment receives approval of second SBIC license - Saratoga Investment Corp. announced that it has received notification from the Small Business Administration that the Company's application for a second Small Business Investment Company license has been approved. The new license will provide up to $175M in additional long-term capital in the form of SBA debentures. As a result of the 2016 omnibus spending bill signed into law in December 2015, the maximum amount of SBA-guaranteed debentures that affiliated SBIC funds can have outstanding was increased from $225M to $350M. With this license approval, Saratoga will grow its SBA relationship from $150M to $325M of committed capital.
|
MYOK | Hot Stocks08:32 EDT MyoKardia begins dosing in Phase 1 clinical study of MYK-224 - MyoKardia announced that it has dosed the first subjects in a Phase 1 clinical study of MYK-224, a small molecule candidate being developed for the treatment of hypertrophic cardiomyopathy. HCM is a progressive disease in which the excessive contraction of the heart muscle and reduced ability of the left ventricle to fill can lead to the development of debilitating symptoms and cardiac dysfunction, ranging from shortness of breath and reduced exercise capacity to heart failure and sudden cardiac arrest. MYK-224 selectively targets cardiac myosin, the heart's motor protein, with the aim of normalizing contractility and filling. The Phase 1 clinical trial is intended to evaluate the safety, tolerability and pharmacokinetics of MYK-224. The trial is a randomized, placebo-controlled, single and multiple-ascending dose study that will enroll adult healthy volunteers into cohorts of eight, randomized 3:1 to MYK-224 or placebo. Pharmacodynamic effects on cardiac function and dimensions will also be assessed using echocardiography. MyoKardia anticipates providing topline results from the Phase 1 study in mid-2020. MYK-224 joins MyoKardia's growing portfolio of therapeutic candidates targeting sarcomeric proteins of the heart muscle to address cardiovascular diseases of excessive or insufficient contraction or impaired relaxation. MyoKardia's lead clinical-stage therapeutic candidate for HCM, mavacamten, is currently being studied in the Phase 3 EXPLORER-HCM clinical trial for the treatment of obstructive HCM, where topline data are expected in Q2 2020, and in the Phase 2 MAVERICK-HCM clinical trial in non-obstructive HCM, where topline data are expected in Q4 of this year.
|
CPST | Hot Stocks08:32 EDT Capstone executes additional 1.7 MW long-term service contracts - Capstone Turbine announced that E-Finity Distributed Generation, Capstone's exclusive distributor for the Mid-Atlantic and Southeastern United States, and the Caribbean, signed Factory Protection Plan long-term service contracts covering 1.7 megawatts of Capstone microturbines in the Marcellus and Utica shale regions in the Appalachian Basin. This large oil and gas end-use customer of Capstone microturbine energy systems had already placed 3.2 MWs under FPP service contracts in June 2019 and now has their entire fleet of 4.9 MWs operating in the Appalachian Basin covered under Capstone's industry-leading FPP product. The Capstone microturbines, commissioned between 2011 and 2016, are used for 24x7 prime power in nine separate midstream central gathering facilities. "The transition of oil and gas customers to the Capstone FPP service contracts is a strong indicator for the continued top and bottom-line growth of our aftermarket service business," stated Darren Jamison, Capstone's President and CEO. "The aftermarket service business was approximately 47% of Capstone's fiscal Q1 2020 revenue and accounted for approximately 97% of the gross margin."
|
JMIA | Hot Stocks08:26 EDT Jumia Technologies terminates, suspends employees involved in improper sales - As disclosed in the prospectus dated April 11, Jumia Technologies received information alleging that some of its independent sales consultants, members of its JForce program in Nigeria, may have engaged in improper sales practices. In response, the company launched a review of sales practices covering all countries of operation and data from January 1, 2017 to June 30. In the course of this review, the company identified several JForce agents and sellers who collaborated with employees in order to benefit from differences between commissions charged to sellers and higher commissions paid to JForce agents. The transactions in question generated approximately 1% of GMV in each of 2018 and Q1 and had virtually no impact on 2018 or 2019 financial statements. Jumia Technologies terminated the employees and JForce agents involved, removed the sellers implicated and implemented measures designed to prevent similar instances in the future. The review of this matter is closed. More recently, the company also identified instances where improper orders were placed, including through the JForce program, and subsequently cancelled. Based on findings to date, the company believes that the transactions in question generated approximately 2% of GMV in 2018, concentrated in Q4, approximately 4% in Q1 and approximately 0.1% in Q2. These 0.1% have already been adjusted for in the reported GMV figure for Q2. These transactions had no impact on financial statements. The company suspended the employees involved pending the outcome of the review.
|
BMRA | Hot Stocks08:24 EDT Biomerica gets clearance to sell colorectal cancer screening test in Colombia - Biomerica announced the Republic of Colombia Ministry of Health and Social Protection Institute National Surveillance of Drugs and Food has granted clearance for Biomerica's EZ Detect colorectal screening test, which detects an early warning sign of colorectal cancer, to be imported and sold in Colombia. The EZ Detect colorectal screening test is the simplest in-home test to detect fecal occult blood, an early warning sign of colorectal cancer. This in-home test does not require handling of stool or any dietary restrictions.
|
SJR | Hot Stocks08:22 EDT Shaw sees 'long-term negative consequences' to Canadians from CRTC decision - Shaw Communications said there will be long-term negative consequences to Canadians from the CRTC's decision to dramatically reduce federally regulated wholesale broadband prices charged to third party internet providers. "We cannot understand the CRTC's rationale for drastically reducing the wholesale broadband rates available to third party internet resellers," said Brad Shaw, CEO of Shaw Communications. "In time, this decision will be seen as short-sighted, and have negative far-reaching consequences for consumers and for the future investment required to build network capacity in all parts of Canada." As a result of the reduced wholesale rates, which the CRTC requires to be applied retroactively to January 2017, Shaw will incur a one-time charge of approximately $10M in its fourth quarter results for fiscal 2019. "While the CRTC appears to be trying to use the reseller market as a primary source of broadband competition, it is ignoring the fact that the resale model relies on the investments of facilities-based providers like Shaw to create robust, fast and reliable networks for the future," Mr. Shaw said. "In light of the decision, we are reviewing our future plans for capital expenditure and network deployment." In its August 7, 2019 study of broadband competition in Canada, the Competition Bureau noted that "facilities-based competitors engage in a dynamic form of competition to successively introduce better networks over time through investments in new technologies." Importantly, the study also noted "wholesale access regulation can have a negative effect on the willingness of facilities-based competitors to make the necessary investments to maintain and evolve their networks."
|
TGT | Hot Stocks08:21 EDT Target expects to deliver strong digital sales fulfillment from stores over time - Management says stores can keep up with digital sales volume.
|
BCDA | Hot Stocks08:19 EDT BioCardia expects DSMB readout of Phase III CardiAMP trial in Q3 - The company said, "Anticipated Upcoming Milestones: Q3 2019: Data and Safety Monitoring Board readout of Phase III CardiAMP Heart Failure Trial. Q3 2019: First commercial sale of AVANCE steerable introducer. Q4 2019: FDA acceptance of the CardiALLO IND application. Q3 2020: Completion of enrollment in the CardiAMP Heart Failure Trial."
|
TGT LEVI | Hot Stocks08:18 EDT Target expanded Levi Strauss partnership to 50 stores - Comments taken from Q2 earnings conference call.
|
BCDA | Hot Stocks08:17 EDT BioCardia expects to begin commerical sale of AVANCE steerable introducer in Q3 - The Company received 510(k) clearance from the FDA for the BioCardia 8.5F AVANCE steerable introducer, indicated for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum. Commercial sale of this new product is anticipated to begin in third quarter 2019.
|
CDNA | Hot Stocks08:14 EDT CareDx says survey shows fear of rejection is transplant patient's top concern - CareDx announced results of a national informational survey conducted with The American Association of Kidney Patients of kidney transplant recipients that assessed their key concerns about monitoring kidney health post-transplant. A total of 170 adults who have received a kidney transplant within the last ten years participated in an online survey which aimed to collect self-reported quantative and qualitative insights to better understand key concerns of patients with a kidney transplant and overall health monitoring. Key insights from the study included:Fear of organ rejection was the number one health concern reported, over 50% of respondents were very or extremely concerned about rejection. 35% of patients stated they skip some medications each month, making compliance a significant issue. Lack of health insurance/cost of medications was shown to be the leading barrier in taking immunosuppressant drugs as prescribed. Of the 114 respondents who reported having a kidney biopsy, only 30% confirmed active rejection. 86% of respondents said they'd prefer, instead of a biopsy, a blood test that gave information specifically about active rejection in a timely and non-invasive way. Most respondents felt timeliness, precise information, and minimally-invasive testing were extremely important when monitoring for rejection of their transplanted organ.
|
NTWK | Hot Stocks08:11 EDT NetSol Technologies says OTOZ creates AI-powered 'chatbot' - NETSOL Technologies has provided an update on the efforts within its on-demand mobility platform OTOZ as well as its ongoing strategic partnership with Drivemate. As previously announced in March of this year, the OTOZ Innovation Lab team has been focused on strengthening the current Drivemate platform with a specific emphasis on efficiency, security and scalability. As the first in a number of planned rollouts, OTOZ is announcing the creation of an artificial intelligence-powered "chatbot" that is intended to cater to renters and car owners, which will be integrated into the current Drivemate chat application LINE. Historically, Drivemate has utilized a high number of customer service representatives to respond to different types of incoming queries such as booking, checking vehicle availability, and pricing. Through internal research and data, it was discovered that Drivemate renters would rather speak with a CSR than communicate via the Drivemate application. Additionally, Drivemate owners would frequently reach out to Drivemate directly to change their car availability dates among other requests. Both group preferences collectively contributed to a high volume of requests for CSRs to handle, leading to high response times on LINE as well as other unintended issues, which collectively impacted customer experience. The OTOZ AI-powered chatbot was created to address all these issues.
|
MDRX | Hot Stocks08:10 EDT Allscripts business unit enters research partnership with Komodo Health - Veradigm, an Allscripts business unit, announced that it has entered into a long-term strategic partnership with Komodo Health to advance life sciences research. Initially the partnership will focus on linking Allscripts' ambulatory EHR data with Komodo's Healthcare Map, which contains encounter data from more than 150 private and public payers. Using Komodo Health's platform, the collaboration will enable Veradigm to provide a linked dataset containing a complete longitudinal view of nearly 50M deidentified patients to support life sciences companies as they investigate new ways to reduce disease burden. The linked dataset combines detailed clinical and patient lifestyle information along with cost and utilization data captured across all care settings. Veradigm's model for real-world research is built on access to near real-time patient data, analytics and point-of-care programs. By linking the largest ambulatory EHR for life science research dataset with Komodo's Healthcare Map, Veradigm leverages each source to offer researchers opportunities to integrate patient history and behavior, detailed clinical symptoms and outcomes, patterns of drug and health services utilization, along with costs to individuals and payers.
|
ORA | Hot Stocks08:07 EDT Ormat Technologies announces closing of $59.3M partnership transaction - Ormat Technologies announced that one of its wholly owned subsidiaries that owns the 48MW McGinness Hills Phase 3 Geothermal power plant entered into a partnership agreement with a private investor. Under the transaction documents, the private investor acquired membership interests in the project for an initial purchase price of approximately $59.3M and for which it will pay additional annual installments that are expected to amount to a total of approximately $9M. Ormat will continue to operate and maintain the power plant and will receive substantially all of the distributable cash flow generated by the power plant, and the private investor will receive substantially all of the tax attributes. The McGinness Hills Phase 3 geothermal power plant, located in Lander County, Nevada, began commercial operation on December 15, 2018. The project sells its power under the 26-year Ormat Northern Nevada Geothermal Portfolio Power Purchase Agreement with Southern California Public Power Authority, which was announced in June 2017.
|
TEVA | Hot Stocks08:07 EDT Teva publishes Phase 3b FOCUS study results - Teva announced that results from the Phase 3b FOCUS study, which examined fremanezumab versus placebo in adult migraine patients who previously experienced inadequate responses to two to four classes of preventive treatments, were published online ahead of print in The Lancet. The study found fremanezumab was superior versus placebo across all primary and secondary endpoints. The primary outcome measure of the trial was mean change from baseline in the monthly average number of migraine days during the 12-week treatment period following the first dose. Treatment resulted in statistically significant reductions in monthly average number of migraine days in participants who received either monthly or quarterly dosing with fremanezumab during the study. Fremanezumab is approved in the U.S. and Europe for the preventive treatment of migraine in adults. The FOCUS study, a randomized, double-blind, parallel-group, placebo controlled study, evaluated the efficacy of two dosing regimens of fremanezumab in a large population of adult patients with episodic or chronic migraine who had documented prior inadequate response within the past ten years to two-to-four pharmacological classes of migraine preventive medications: beta blockers, anticonvulsants, tricyclic antidepressants, calcium channel blockers, angiotensin II receptor antagonists, onabotulinumtoxinA, or valproic acid. Between November 2017 and July 2018, 838 patients with episodic or chronic migraine were randomized by electronic interactive response technology, or IRT, at 104 sites in 14 countries to placebo, quarterly fremanezumab, or monthly fremanezumab. Both patients with and without overuse of acute headache medication were included. Reductions from baseline in monthly days with migraine, moderate to severe headache, or use of acute headache medications were about 3.5 days greater with fremanezumab than with placebo. The odds relative to placebo for achieving a greater than or equal to 50% reduction in migraine days as early as four weeks after starting study treatment were approximately six-fold higher with fremanezumab. Patients treated with fremanezumab had 3.1- to 3.8-day greater reductions in migraine days across dosing and migraine classification subgroups than patients receiving placebo, representing a therapeutic gain of 26 to 39 percentage points. The most common adverse reactions in the study were injection site reactions. Less than 1% of patients in the fremanezumab group experienced an adverse event leading to discontinuation. Patients with major comorbid diseases, including major cardiovascular disease, were excluded from participation in this study.
|
ORA | Hot Stocks08:06 EDT Ormat Technologies announces closing of $53.9M partnership transaction - Ormat Technologies announced that one of its wholly owned subsidiaries that owns the 48MW McGinness Hills Phase 3 Geothermal power plant entered into a partnership agreement with a private investor. Under the transaction documents, the private investor acquired membership interests in the project for an initial purchase price of approximately $59.3M and for which it will pay additional annual installments that are expected to amount to a total of approximately $9M. Ormat will continue to operate and maintain the power plant and will receive substantially all of the distributable cash flow generated by the power plant, and the private investor will receive substantially all of the tax attributes. The McGinness Hills Phase 3 geothermal power plant, located in Lander County, Nevada, began commercial operation on December 15, 2018. The project sells its power under the 26-year Ormat Northern Nevada Geothermal Portfolio Power Purchase Agreement with Southern California Public Power Authority, which was announced in June 2017.
|
SNDL | Hot Stocks08:06 EDT Sundial Growers expands into Saskatchewan - Sundial Growers has successfully entered the Saskatchewan market with its recent shipment of high-quality cannabis. As part of the recent approval by Health Canada to amend Sundial's Standard Cultivation and Standard Processing licences, Sundial has added 34 additional purpose-built modular cultivation rooms. Each of these rooms provide the optimal growing environment for consistent high-quality batches of cannabis and nearly double the number of existing rooms in operation. The additional supply will also help meet market demand in provinces, such as Saskatchewan. Sundial cannabis is now available in Alberta, Saskatchewan, Manitoba and Ontario.
|
ANF | Hot Stocks08:05 EDT Abercrombie & Fitch becomes participant of United Nations Global Compact - Abercrombie & Fitch Co. announced that it has become a participant of the United Nations Global Compact, the world's largest corporate citizenship and sustainability initiative. The company also announced its new sustainability targets through 2025. Key goals include: Responsibly sourcing materials with sustainable processes or from recycled fibers by 2025, including cotton, polyester, viscose, wool, down and linen; Driving 30 percent water reduction in denim production by 2022; Partnering with its vendor partners on training programs, including human trafficking prevention and health & wellbeing, and capacity building to support the training of 75,000 additional workers by 2022. These targets, and others detailed on its website, align with the UN's Sustainable Development Goals , which address global challenges such as poverty, inequality, climate, environmental degradation, prosperity and peace and justice. The company's participation in the Compact and its new set of goals build on the retailer's existing global social and environmental sustainability programs, many of which were started almost 20 years ago. As a signatory of the Compact, A&F Co. supports and commits to the Compact's Ten Principles on human rights, labor, environment and anti-corruption. A&F Co. also will participate in two Action Platforms, which advance responsible corporate action and focus on critical issues related to the Compact's SDGs. Through the "Water Security through Stewardship" and "Reporting on SDGs" platforms, A&F Co. will learn additional best practices to address social, economic and environmental issues related to water and sanitation, as well as methods for capturing, analyzing and reporting performance against the various SDGs, respectively. As part of its commitment to the Compact, A&F Co. will complete an annual Communication on Progress submission in 2020. The COP will provide transparency into A&F Co.'s progress towards the UN Global Compact's Ten Principles.
|
HOTH | Hot Stocks08:04 EDT Hoth Therapeutics and Zylo Therapeutics finalize agreement on Lupus drug - Hoth Therapeutics has entered into a definitive partnership agreement with Zylo Therapeutics to develop a new treatment for patients suffering from Cutaneous Lupus Erythematosus, a chronic autoimmune disease that affects the skin. Zylo Therapeutics has developed a patented topical delivery system using xerogel-derived nanoparticles called Z-pods, Hoth has an exclusive license to develop Anandamide-loaded Z-pods for the treatment of CLE in North America. Anandamide, generally referred to as AEA, is one of the cannabinoids that the human body makes naturally. Hoth also has certain rights related to geographic expansion and to follow-on indications such as psoriasis and rheumatoid arthritis. Scientists have demonstrated that topical administration with AEA-loaded Z-pods inhibits the development of CLE lesions in a well-established animal model of lupus. This work reinforces and highlights the utility of targeting the endocannabinoid system for autoimmune rheumatic diseases.
|
SLNG | Hot Stocks08:03 EDT Stabilis Energy reports transactions to enhance LNG, CNG capabilities in Mexico - Sabilis Energy announced two strategic transactions that will expand its presence in the distributed liquefied natural gas and compressed natural gas markets in Mexico. Stabilis has completed the acquisition of privately held Diversenergy, LLC and its subsidiaries to create one of the leading distributed LNG marketing and distribution companies in Mexico, the company said in a statement. In addition, Stabilis has completed the formation of a joint venture with Grupo CLISA and other former owners of Diversenergy to pursue investments in LNG and CNG assets in Mexico.
|
GTLS BHGE | Hot Stocks08:03 EDT Chart Industries receives FNTP for Venture Global's Calcasieu Pass project - Chart Industries (GTLS) has received full notice to proceed for the production of cold boxes and brazed aluminum heat exchangers for Venture Global's 10 MTPA Calcasieu Pass liquefied natural gas export terminal project. This week Venture Global announced final investment decision and the closing of the project financing for their Calcasieu Pass LNG facility and associated TransCameron pipeline in Cameron Parish, Louisiana. The proceeds of the debt and equity financing fully fund the balance of the construction and commissioning of Calcasieu Pass. Full site construction began in February 2019 and the Commercial Operations Date is expected in 2022. At the end of March 2019, Chart booked the full equipment order of $135M for the Calcasieu project from Baker Hughes (BHGE). On Tuesday, August 20, 2019, BHGE announced that it has been awarded a contract and granted notice to proceed on the construction of a comprehensive LNG technology solution for the project. Chart will deliver the equipment on a multi-year schedule in conjunction with BHGE and Kiewit.
|
IMBI EVLV | Hot Stocks07:42 EDT iMedia Brands rebrands Evine shopping network to ShopHQ - iMedia Brands completed the on-air rebranding of its flagship, nationally distributed shopping entertainment network to ShopHQ, capping a six-week awareness campaign with its customers across its television, online, mobile and social media platforms. The company said, "The changes include: New name. We now better understand that the 2015 name change from ShopHQ to Evine was confusing and ineffective. We fixed that in a collaborative fashion over the last six weeks with our vendors and customers. New sets...New hosts...New loyalty program. In November, we are planning to roll out an exclusive, new loyalty program called ShopHQ VIP. This innovative new program will enable our customers to earn cash back, enjoy free shipping and participate in discounts at other retailers in our loyalty network. New website. Over the next three months, our customers will begin to enjoy improvements to the interactive experiences on all our platforms, from desktop to mobile and from home page to emails."
|
JPM | Hot Stocks07:41 EDT JPMorgan says closing Chase Pay app in early 2020 - JPMorgan Chase said on its website that it is closing the Chase Pay app in early 2020. "After that, you'll no longer be able to download or use the app," the company said. It added, "We're partnering with even more of your favorite online retailers and merchant apps to add Chase Pay as an option at checkout. Because customers like you deserve a simple, rewarding and secure way to pay." "Until early 2020, you can continue to use Chase Pay wherever you see the Chase Pay logo in-store, online, and in merchant apps. Once we close the app, you can still use Chase Pay to check out on participating merchant websites and apps." Reference Link
|
RCI | Hot Stocks07:38 EDT Rogers Communications launches Ignite TV in New Brunswick - Rogers announced that its IPTV service, Ignite TV, is now available across New Brunswick. This innovative TV service deeply integrates the best content available and revolutionizes the entertainment experience. Initially an English-only service in Canada, Ignite TV is now officially available in both of our national languages. Customers can search for their favourite content and navigate the platform in both French and English using their voice. Uniquely designed for New Brunswick customers, employees across the province helped perfect voice technology in both northern and southern Acadian accents. More than 500 New Brunswick employees helped test and perfect Ignite TV, including every part of the customer experience.
|
EBIX | Hot Stocks07:35 EDT FIDx announces strategic partnership with Ebix for annuity offerings - FIDx announced a strategic partnership with Ebix. Acting as a bridge between insurance carriers and wealth managers, FIDx and Ebix have partnered to help advisors access a pool of annuity offerings into investment portfolios and address their clients financial planning needs.
|
ADS | Hot Stocks07:35 EDT Alliance Data reports final results of modified Dutch auction tender offer - Alliance Data announced the final results of its "modified Dutch Auction" tender offer, which expired on August 15. A total of 12,099,724 shares of Alliance Data's shares of common stock, 1c par value per share, were properly tendered and not properly withdrawn at or below the purchase price of $162.00 per share. Alliance Data has accepted for purchase 5,050,505 shares at a price of $148.50 per share, for an aggregate cost of approximately $750M, excluding expenses, representing approximately 9.92% of the shares outstanding as of August 14. The final proration factor for shares that Alliance Data has purchased pursuant to the tender offer is approximately 91.72%.
|
CURR | Hot Stocks07:29 EDT CURE Pharmaceutical signs deal with hemp grower Fytiko Farms - CURE Pharmaceutical announced it has signed a deal with Oklahoma-based hemp grower Fytiko Farms. The deal gives CURE direct, guaranteed access to high-quality plant material for exclusive use in its proprietary oral thin film drug delivery system, CUREfilm. The deal provides access to high-quality organic hemp extracts for use in CURE products through strain improvement, cannabinoid extraction process development, biomarker identification and quality control testing.
|
BMIX | Hot Stocks07:24 EDT Brazil Minerals says diamond and gold mining operations 'progressing well' - Brazil Minerals announced that its alluvial diamond and gold project mining operations are progressing well and within its plans for production in the third quarter of 2019. This project is in the Jequitinhonha River Valley of the state of Minas Gerais, Brazil, and in a district known for retrieval of diamonds and gold for over two centuries. Brazil Minerals, through subsidiaries, has title to over 27,000 acres of mineral rights for diamonds and gold in this region. In the current mining site, excavation has reached a depth of approximately 25 feet. Between 35 to 50 feet in depth the desired auriferous and diamondiferous gravel layer appears, followed by bedrock at about 60 feet. The Company also announced that it had completed a few additional drilling holes prior to excavation in areas just adjacent to the current target site. In one of these areas, the auriferous and diamondiferous gravel layer was found to be over 20 feet in thickness, which is highly attractive, and provided valuable indication as to future direction for project expansion.
|
CSIQ | Hot Stocks07:22 EDT Canadian Solar to provide services for three solar power plants in Australia - Canadian Solar has signed Operations & Maintenance agreements with Gannawarra Solar Farm, Hayman Solar Farm and Daydream Solar Farm for three solar PV plants totaling 300 MWp in Australia. Canadian Solar will be responsible for plant monitoring, performance management, and preventative and corrective maintenance in all three facilities.
|
RDHL | Hot Stocks07:17 EDT RedHill Biopharma announces acceptance of oral presentations on RHB-105 - RedHill Biopharma announced that it will present data from the positive Phase 3 clinical studies of RHB-105 for H. pylori infection and RHB-104 for Crohn's disease at the upcoming American College of Gastroenterology 2019 Annual Scientific Meeting. In addition, an oral presentation on RHB-105 was also accepted for presentation at the XXXIInd International Workshop on Helicobacter & Microbiota in Inflammation and Cancer of the European Helicobacter and Microbiota Study Group .
|
TNXP | Hot Stocks07:14 EDT Tonix Pharmaceuticals, MGH enter research collaboration for TNX-1500 - Tonix Pharmaceuticals Holding announced the signing of a research collaboration agreement with Massachusetts General Hospital, a teaching hospital of Harvard Medical School, to develop TNX-1500, a humanized monoclonal antibody that targets CD154 for the prevention and treatment of organ transplant rejection. TNX-1500 is another step in the strategic broadening of Tonix's portfolio of high-value programs, whose risk is mitigated by previous clinical data and extensive preclinical science. Although transplantation is the first targeted indication for TNX-1500, it is also a potential treatment for autoimmune conditions including systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis. Tonix and MGH have agreed to work jointly under a research agreement which will bring together Tonix's internally developed, proprietary anti-CD154 mAb, TNX-1500, with transplantation experts from MGH, led by Richard N. Pierson III, M.D., scientific director of the Center for Transplantation Sciences in the Department of Surgery at MGH and Professor of Surgery at Harvard Medical School. The goal of the collaboration is to advance TNX-1500 as a potential first-in-class therapeutic for organ transplant rejection. Transplant organ rejection occurs when the immune system of the organ recipient attacks the new organ as if it was an infection or tumor.
|
CARA | Hot Stocks07:13 EDT Cara Therapeutics announces commercial license agreement with Enteris BioPharma - Cara Therapeutics announced that it has entered into a non-exclusive commercial license agreement with Enteris BioPharmaInc. for oral formulation rights to Enteris' Peptelligence Technology. Under the terms of the License Agreement, Enteris granted Cara a non-exclusive license to its Peptelligence Technology to develop and commercialize Oral KORSUVA in any indication worldwide, excluding South Korea and Japan. Enteris will receive an upfront payment of $8M, including $4M in cash and $4M in Cara common stock. Enteris is also eligible to receive development, regulatory and tiered commercial milestone payments, as well as low, single-digit royalties based on net sales in the licensed territory. Cara retains the right to buy out the royalty obligation for a period of two years under prespecified conditions.
|
ALT | Hot Stocks07:11 EDT Altimmune announces $3.7M in additional BARDA funding to develop NasoShield - Altimmune announced that the Biomedical Advanced Research and Development Authority is modifying its existing anthrax vaccine development contract with Altimmune by awarding an additional $3.7M. The increase in funding is primarily directed toward a Phase 1b clinical trial of NasoShield to evaluate alternative methods of intranasal dosing in humans. In 2018, BARDA awarded Altimmune $2.5M for further NasoShield development including a comparison of different methods of administration of the vaccine in preclinical models. The data from this study demonstrated that a simple modification to the method of intranasal dose administration had a dramatic impact on the resulting immunogenicity. These results suggest that the 2018 Phase 1 study of NasoShield in healthy adults might have shown a more robust immunogenic effect had a modified administration method been employed. The planned Phase 1b clinical trial will evaluate modified methods of intranasal dosing on NasoShield safety and immunogenicity and is expected to start in 2019.
|
RARX MRK | Hot Stocks07:10 EDT RA Pharmaceuticals earns clinical milestone for macrocyclic peptide - Ra Pharmaceuticals (RARX) announced that it has earned a clinical development milestone under its collaboration agreement with Merck (MRK). The milestone is associated with the dosing of the first patient in a Phase 1 clinical trial evaluating an investigational orally-available macrocyclic peptide for a non-complement cardiovascular target with a large market opportunity from the companies' collaboration. Initiated in 2013, the Merck collaboration leverages Ra Pharma's extreme diversity platform aimed at producing macrocyclic peptides that are designed to have the diversity and specificity of antibodies, while retaining the pharmacologic attributes of small molecules, with the potential to allow for the rapid identification, design, and development of drug-like peptides with high stability, bioavailability, cell permeability and potency. Under the terms of the agreement, Ra Pharma is eligible to earn up to $56M in additional milestone payments from Merck based upon the achievement of development, regulatory and commercialization milestones. Ra Pharma is also eligible to receive low-to-mid single digit percentage royalties on any future sales of compounds resulting from the collaboration.
|
CARA | Hot Stocks07:09 EDT Cara Therapeutics licenses Enteris BioPharma's Peptelligence for Korsuva program - Cara Therapeutics and Enteris BioPharma, a biotechnology company developing drug products built around its proprietary oral peptide delivery technologies, entered into a definitive licensing agreement for Enteris' Peptelligence technology in the ongoing development of an oral formulation of Cara's first-in-class KOR agonist, CR845/difelikefalin - Korsuva. Peptelligence is Enteris' proprietary platform for the oral delivery of peptides and BCS class II, III and IV small molecules. The oral tablet formulation of Korsuva was engineered using Peptelligence. Oral Korsuva is currently the subject of three separate Phase 2 clinical trials for pruritis in patients with hepatic impairment due to primary biliary cholangitis, stage III-V chronic kidney disease, and atopic dermatitis. The agreement will allow Cara to continue its Oral Korsuva programs into Phase 3 and beyond. Under the terms of the deal, Enteris granted to Cara Therapeutics a non-exclusive, royalty-bearing license to the Peptelligence technology to develop, manufacture and commercialize Oral Korsuva worldwide, excluding Japan and South Korea. In exchange, Enteris will receive an upfront payment equal to $8M, with 50% payable in cash and 50% payable in shares of Cara's common stock. Cara is also obligated to pay Enteris milestone payments upon the achievement of certain development, regulatory and commercial milestones and low-single digit royalties based on net sales in the licensed territory. Cara retains the right to buy-out the royalty obligation for a period of two years under prespecified conditions.
|
PLCE | Hot Stocks07:09 EDT Children's Place reports Q2 comparable retail sales decrease of 3.8%.
|
AIMT | Hot Stocks07:07 EDT Aimmune enrolls first patient in Phase 2 trial of AR201 - Aimmune Therapeutics announced that it has randomized its first patient in a phase 2 clinical trial of AR201 for the treatment of egg allergy. AR201, an investigational biological drug for use in oral immunotherapy for egg allergy, is the second development program that Aimmune is advancing to phase 2 using its Characterized Oral Desensitization ImmunoTherapy platform.
|
DXC NOW | Hot Stocks07:05 EDT DXC Technology acquires ServiceNow partner Syscom - DXC Technology (DXC) announced the acquisition of Syscom, a ServiceNow (NOW) partner, to extend the reach and scale of its security operations and service management capabilities. The acquisition of Syscom extends DXC's expertise as a global ServiceNow solutions provider. Syscom, founded in 1987, is an independent provider of service management and security consulting and solutions in Norway. The acquisition expands DXC's presence in Norway. The addition of Syscom is the company's third recent acquisition of digital service management capabilities in the region, following the acquisitions of Logicalis SMC in the Netherlands and BusinessNow in Denmark.
|
VNDA | Hot Stocks07:03 EDT Vanda Pharmaceuticals names Joakim Wijkstrom as Chief Marketing Officer - Vanda Pharmaceuticals announced that it has named Aranthan "AJ" Jones II as its Chief Corporate Affairs and Communications Officer and Joakim "Kim" Wijkstrom as its Chief Marketing Officer. Jones II and Wijkstrom will report directly to Mihael Polymeropoulos, M.D., Vanda's President and CEO. Prior to joining Vanda, Jones II served as Global Head of Public Affairs for Burson Cohn & Wolfe where he counseled Fortune 500 clients on corporate affairs and communications, investor relations, government relations, public policy and social impact initiatives. Prior to this position, Jones II was a senior executive at the W.K. Kellogg Foundation, and was formally the Worldwide Head of Government Affairs for Gilead Sciences. Wijkstrom has held Chief Marketing Officer positions at Perry Ellis and One Main Financial.
|
CAH | Hot Stocks06:59 EDT Cardinal Health warns opioid-related lawsuits could impact business - Cardinal Health's business could be impacted by ongoing opioid-related lawsuits, the company warned in a regulatory filing. Cardinal said in the filing it expects to be named as a defendant in additional lawsuits. The company said it was vigorously defending itself in all opioid-related matters, but is unable to predict their outcome or estimate a range of reasonably possible losses, and added that ongoing negative publicity could hurt the its reputation or results of operations.
|
SMED | Hot Stocks06:57 EDT Sharps Compliance: 'FY20 should benefit from growth in all solution offerings' - CEO David Tusa concluded, "Looking forward to fiscal 2020, we see the September 2019 quarter shaping up as strong and believe the full fiscal year 2020 should benefit from growth in all solution offerings and markets. Our growth is being driven not only by the Company's successful transformation to a comprehensive solutions provider but also our focus on customer service, reasonable contract terms and fair pricing in markets, which we believe are vastly underserved."
|
FET | Hot Stocks06:55 EDT Forum Energy to sell 40% interest in Ashtead Technology for $47.8M - Forum Energy's subsidiaries have entered into a definitive agreement to sell their aggregate 40% interest in Ashtead Technology, a subsea rentals company. Total consideration for Forum's interest and the settlement of a Forum GBP 3 million loan to Ashtead will be $47.8M. Forum will receive approximately $39M in cash proceeds at close and a new approximately GBP7M loan with a three year maturity. The transaction is expected to close in Q3. The buyers of Forum's interest are Buckthorn Partners and other investors that currently own the majority of the equity interests in Ashtead. Cris Gaut, Forum's Chairman and Chief Executive Officer, commented, "The significant proceeds from this transaction will be used to further reduce debt, accelerating Forum's debt reduction strategy. Over the last three quarters, Forum's strong free cash flow generation has allowed us to reduce our net debt by approximately $54M, and we expect this momentum to continue in the second half of 2019". Ashtead Technology provides technically advanced subsea solutions, sensors, tools and systems. Forum became an investor in 2018 when it contributed its Forum Subsea Rentals products in exchange for a 40% equity interest in Ashtead. Ashtead contributed approximately $2.5M of equity income excluding basis difference amortization to Forum's results in the last twelve months ended June 2019.
|
WEX | Hot Stocks06:48 EDT Wex signs multi-year extension as exclusive provider for Phillips 66 - Wex has signed a multi-year extension to be the exclusive provider of private label and universal fleet card services for Phillips 66. Wex and Phillips 66 have partnered since 2010 to develop a comprehensive sales and marketing engine that relies on emerging payment technologies to support fleet customers and independent marketers and dealers at more than 7,000 fueling locations.
|
DSGX | Hot Stocks06:48 EDT Descartes Systems acquires BestTransport for $11.2M - Descartes Systems announced that it has acquired BestTransport.com, a cloud-based transportation management system provider focused on flatbed-intensive manufacturers and distributors. BestTransport is headquartered in Columbus, OH. Descartes acquired BestTransport for $11.2M, net of working capital, satisfied from Descartes' existing line of credit.
|
PBA KMI | Hot Stocks06:47 EDT Pembina Pipeline to acquire Kinder Morgan Canada, pipeline portion for $4.35B - Pembina Pipeline (PBA) announced that it has entered into agreements pursuant to which it will acquire Kinder Morgan Canada and the U.S. portion of the Cochin Pipeline system from Kinder Morgan (KMI) for a total purchase price of approximately $4.35B. The transaction values Kinder Morgan Canada at approximately $2.3B, or $15.02 per share, based on an all-share exchange ratio of 0.3068 of a common share of Pembina per KML security and Pembina's 30-day volume weighted average price on the date hereof; and Cochin U.S. at approximately $2.05B for cash consideration. Subject to closing of the transaction, Pembina's board of directors has also approved a 1c per common share, or approximately 5%, increase to its monthly common share dividend rate. Through the transaction, Pembina will acquire assets including the Cochin Pipeline System, the Edmonton storage and terminal business and Vancouver Wharves, a bulk storage and export/import business. Upon closing, the transaction immediately provides Pembina with business platforms and opportunities for growth. The Cochin mainline system represents a fully contracted cross-border pipeline system that is strategic as it connects Pembina's Channahon, Bakken and Edmonton area assets and is connected to markets in Mont Belvieu, Conway and Edmonton. Further, there is future potential to connect the eastern leg of the Cochin Pipeline System to Pembina's assets and markets in Sarnia, Ontario. As well, the corporate acquisition includes a crude oil storage and terminalling business in Western Canada's energy complex, which connects Pembina's conventional and oilsands pipelines to all export pipelines, providing increased flexibility and greater egress options to customers. Finally, there is potential for further integration of Vancouver Wharves assets into the Pembina value chain. The assets to be acquired under the transaction are predominantly supported by long-term, fee-for-service, take-or-pay contracts, which are underpinned by investment grade counterparties. The transaction strengthens Pembina's financial guardrails and hence Pembina as a whole.The transaction will be immediately accretive to adjusted cash flow per share and increases the company's fee-for-service and take-or-pay component of adjusted EBITDA. The assets being acquired in the transaction are expected to generate adjusted EBITDA of approximately $350M in FY19. Through the integration of these assets with the company's existing businesses, Pembina estimates that incremental run-rate adjusted EBITDA of $50M can be realized within five years with nominal capital investment. In addition, Pembina expects the assets could generate an additional $50M of run-rate adjusted EBITDA through expansion opportunities. The transaction represents a unique opportunity for Pembina to acquire 100% of Cochin, which is one of two cross-border condensate import pipelines. Cochin, which spans 2,900 km from Chicago, Illinois to Fort Saskatchewan, Alberta, has a design capacity of up to 110,000 barrels per day and is primarily underpinned by long term, take-or-pay commitments with investment grade counterparties. Cochin complements Pembina's existing condensate infrastructure in Western Canada and extends the company's reach into the U.S., with the potential to provide Pembina and its customers improved market access and tremendous long-term optionality. Cochin has operated both as a condensate import system, and previous thereto, as a propane export system. The transaction also provides Pembina enhanced diversification and an entrance into a new franchise opportunity through a significant crude oil storage terminalling business strategically located in the core of the Edmonton area crude oil complex and underpinned by long-term, fee-based contracts with investment grade counterparties. With 10M barrels of storage capacity, inbound and outbound connectivity and industry fundamentals associated with crude oil storage, Pembina views these assets as attractive in the current environment. The storage business also has a strategic alignment with Pembina's existing conventional and oil sands pipelines and marketing businesses. The storage business also includes direct connectivity to two rail terminals, ownership in which is included in the Transaction. The Transaction also includes Vancouver Wharves, a commodity export and import business in the Port of Vancouver, Canada's largest port. Vancouver Wharves is a 125 acre bulk marine terminal facility, which transfers over 4M tonnes of bulk cargo annually and is supported by fee-based contracts with creditworthy counterparties and is competitively positioned as the facility-of-choice for key agricultural, mining, and petroleum product customers. Under the terms of the arrangement agreement governing the corporate acquisition, Pembina will acquire all of the issued and outstanding restricted voting shares and special voting shares of Kinder Morgan Canada and all of the class B units of Kinder Morgan Canada Limited Partnership by way of a plan of arrangement under the Business Corporations Act. Pembina is offering to acquire each of the outstanding restricted voting shares and each Class B Unit in exchange for 0.3068 of a common share of Pembina, which represents a 32% premium, based on Pembina and Kinder Morgan Canada's 30-day volume weighted average prices of $48.96 and $11.37, respectively, on the date hereof. The corporate acquisition is valued at approximately $2.3B including the assumption of Kinder Morgan Canada's preferred shares and outstanding net debt. The corporate acquisition is subject to approval of at least 66 and 2/3% of holders of restricted voting shares and special voting shares, voting together as a single class and a majority of holders of restricted voting shares, in each case present in person or by proxy at a special meeting of the holders of restricted voting shares and special voting shares to be called to consider the corporate acquisition, approval of the Court of Queen's Bench of Alberta, certain regulatory approvals in Canada and other customary conditions. KMI, who holds all of the special voting shares and a corresponding 70% economic interest in Kinder Morgan Canada's business and assets, has entered into a support agreement pursuant to which it has agreed to vote its special voting shares in favor of the corporate acquisition. The corporate acquisition is also subject to clearance under the Competition Act and the Canada Transportation Act. The Transaction is cross-conditional on the closing of both the corporate acquisition and the Cochin U.S. Acquisition. It has been unanimously approved by the board of directors of the company and is expected to close in the first half of 2020. The arrangement agreement in respect of the corporate acquisition includes customary provisions relating to non-solicitation, fiduciary outs for Kinder Morgan Canada with respect to financially superior alternate proposals and Pembina's right to match such proposals until the date of the Kinder Morgan Canada shareholders' approval of the transaction. The cash consideration associated with the Cochin U.S. Acquisition will be initially funded through the company's $2.5B unsecured credit facility and a new $1B committed term facility. Subsequently, Pembina expects to refinance this with the issuance of medium-term notes.
|
PBA KMI | Hot Stocks06:42 EDT Pembina Pipeline approves 5% increase to monthly dividend - Subject to closing of the Transaction with Kinder Morgan (KMI), Pembina's (PBA) board of directors has also approved a C$0.01 per common share, or approximately 5%, increase to its monthly common share dividend rate.
|
KMI PBA | Hot Stocks06:40 EDT Pembina to acquire Kinder Morgan Canada, Cochin U.S. for C$4.35B - Kinder Morgan (KMI) announced that it has agreed to sell the U.S. portion of the Cochin Pipeline to Pembina Pipeline (PBA) for $1.546B, approximately 13 times 2019 expected EBITDA. Also, Kinder Morgan Canada Limited announced that it reached an agreement with Pembina under which Pembina has agreed to acquire all the outstanding common equity of KML (which includes KMI's 70% stake), subject to the terms of the arrangement agreement between KML and Pembina. The closing of the two transactions are cross-conditioned upon each other. The parties expect to close the transactions late in the fourth quarter of 2019 or in the first quarter of 2020, subject to customary closing conditions, including KML shareholder and applicable regulatory approvals. KMI expects to use the proceeds to reduce debt to maintain its Net Debt-to-Adjusted EBITDA ratio of approximately 4.5 times and use the remaining proceeds to invest in attractive projects and/or to opportunistically repurchase KMI shares. Initially, proceeds will be used to reduce Net Debt. With the cash proceeds from the sale of Cochin alone, and assuming the transaction were to close at the end of 2019, KMI would expect to end 2019 with a Net Debt-to-Adjusted EBITDA ratio of approximately 4.4 times, improved from the approximately 4.6 times year-end projection announced in the second quarter earnings release. KMI will receive .3068 shares of Pembina for each KMI held share in KML. This exchange ratio results in KMI receiving approximately 25M shares of Pembina stock for KMI's 70% interest in KML, which equates to slightly less than 5% of Pembina's common equity. KMI views Pembina as a leading infrastructure services provider to the North American energy industry. Pembina has an integrated asset base serving multiple energy commodities. While KMI expects to ultimately convert these shares into cash, the company plans to do so in an opportunistic and non-disruptive manner. Conversion of these shares to cash at yesterday's closing price for Pembina of C$49.27 would yield pre-tax proceeds of approximately $935M. Based on that closing price, the total consideration to be received by KML common shareholders is valued at C$15.12 per KML share, which represents a 38% premium to yesterday's KML closing price.
|
KMI PBA | Hot Stocks06:37 EDT Pembina to acquire Kinder Morgan Canada, Cochin U.S. for C$4.35B
|
TGT | Hot Stocks06:35 EDT Target up 7.2% after reporting Q2 results, raising FY19 adj. EPS guidance
|
CERC | Hot Stocks06:32 EDT Cerecor's CERC-802 granted Fast Track designation from FDA - Cerecor announced that the FDA has granted Fast Track Designation for CERC-802, an ultra-pure, oral formulation of D-mannose currently in development for the treatment of Mannose-Phosphate Isomerase Deficiency, also known as MPI-CDG or CDG-1b. Simon Pedder, Executive Chairman of the Board for Cerecor, stated, "We're currently collecting retrospective data through the CDG FIRST trial to support a New Drug Application for a much-needed therapy."
|
CVIA | Hot Stocks06:31 EDT Covia names Richard Navarre as President and CEO - Covia announced that its Board of Directors has appointed Richard Navarre President and CEO, effective September 1. In conjunction with Navarre's appointment, he will continue to serve as Covia's Board Chair and Matthew LeBaron has been appointed to serve as the company's Lead Independent Director. Navarre has served as Chairman of the Board of Directors and Executive Committee of Covia since June 2018, and as interim President and CEO since May 2019. He has more than 35 years of leadership in the mining industry, including having previously served as the President and Chief Commercial Officer of Peabody Energy Corporation.
|
RY | Hot Stocks06:16 EDT Royal Bank of Canada reports Common Equity Tier 1 ratio of 11.9% - The company said, "Compared to last quarter, net income was up $33 million with higher earnings in Personal & Commercial Banking, Wealth Management and Insurance, largely offset by lower earnings in Capital Markets and Investor & Treasury Services. Provisions for credit losses on impaired loans ratio of 25 basis points was up 8 bps from a year ago (down 4 bps compared to last quarter), largely due to higher provisions in Capital Markets compared to recoveries in the prior year. Higher provisions in Personal & Commercial Banking also contributed to the increase. Our capital position remained strong with a Common Equity Tier 1 ratio of 11.9%, up 10 bps from last quarter. In addition, today we announced an increase to our quarterly dividend of $0.03 or 3% to $1.05 per share."
|
SCOR | Hot Stocks06:09 EDT comScore announces 8% workforce reduction - In a regulatory filing, comScore announced that it is implementing a reduction in force plan that is expected to result in the termination of approximately 8% of the company's workforce. The reduction in force is being implemented following a determination to reorganize the company's technology, product and sales organizations to optimize its focus on core areas of growth. The majority of the employees impacted by the reduction in force will exit the company in the third quarter. In connection with this reduction in force, the company will incur certain exit-related costs, which are expected to range between $1.5M-$2.5M, consisting primarily of one-time termination benefits and associated costs, to be settled in cash. Together with recent attrition, the reduction in force is expected to decrease the company's annualized operating costs by more than $20M, a portion of which will be realized beginning in the third quarter.
|
AZN | Hot Stocks06:09 EDT AstraZeneca updates on Phase 3 NEPTUNE trial of Imfinzi plus tremelimumab - AstraZeneca announced final overall survival results from the Phase III NEPTUNE trial, a randomized, open-label, multi-center, global trial of Imfinzi in combination with tremelimumab, an anti-CTLA4 antibody, vs. standard-of-care platinum-based chemotherapy in previously-untreated Stage IV non-small cell lung cancer patients. The trial was performed in an all-comers population, and the primary analysis population was patients with a high tumor mutational burden. TMB is a measurement of the number of mutations within the genome of a tumor, and tumors with high levels of TMB may be more visible to the immune system. In the primary analysis population of patients whose blood TMB was 20 or more mutations per megabase, the combination of Imfinzi and tremelimumab did not meet the primary endpoint of improving OS compared to SoC chemotherapy. The safety and tolerability profile for the combination of Imfinzi and tremelimumab was consistent with previous trials. Jose Baselga, Executive Vice President, Oncology R&D said: "We are fully committed to a deep analysis of the vast clinical and biomarker data from this trial to gain further insights to improve Immuno-Oncology approaches for patients with metastatic non-small cell lung cancer." AstraZeneca will submit the full results for presentation at a forthcoming medical meeting. Imfinzi is also being tested as monotherapy in the Phase III PEARL trial, and in combination with chemotherapy with or without tremelimumab in the Phase III POSEIDON trial as part of an extensive late-stage Immuno-Oncology program in Stage IV NSCLC.
|
BEDU | Hot Stocks06:07 EDT Bright Scholar enters agreement with NCCT, NICTR to reform curriculum - Bright Scholar announced that it has entered into agreements with National Center for School Curriculum and Textbook Development, or NCCT, and National Institute for Curriculum and Textbook Research, or NICTR, to jointly establish a research base for fundamental education curriculum reform. Under this agreement, the partners will collaborate to explore new ideas and build a classic example in advancing education as an ongoing initiative to deepen reforms in China's national curriculum.Through this agreement, NCCT and NICTR will assist Bright Scholar in the development of a systematic five-year curriculum plan and an annual curriculum reform guidance. In addition, they will also assist in the optimization of the company's current curriculum that advocates the five core values of Bright Scholar in education. NCCT and NICTR are divisions of Ministry of Education of People's Republic of China providing platforms for national professional research and guidance for curriculum materials.
|
LOW | Hot Stocks06:07 EDT Lowe's up 6.3% after reporting Q2 results, backing FY19 guidance
|
GE... | Hot Stocks06:04 EDT Fitch says GE's insurance business 'below average' in terms of reserves - Many insurers remain under-reserved against the losses associated with long-term care insurance, according to new analysis by Fitch Ratings. "Exposure to the long-term care market remains a plague," says Anthony Beato, Director of Insurance at Fitch Ratings. "It continues to be a risky product despite the adoption of more conservative reserving philosophies that more closely align to its volatile liabilities." Fitch's analysis identifies four insurers with very high exposure to the LTC market and below average reserve adequacy. They include Genworth Financial (GNW), General Electric (GE), UNUM Group (UNM) and Senior Health Insurance Co. of PA. AEGON Americas has moderate exposure but below average reserve adequacy, Fitch said in a statement. Reference Link
|
RY | Hot Stocks06:04 EDT Royal Bank of Canada raises quarterly dividend to C$1.05 from C$1.02 per share
|
SCM | Hot Stocks05:16 EDT Stellus Capital receives approval for second SBIC license - Stellus Capital announced that its wholly-owned subsidiary, Stellus Capital SBIC II, LP, has received approval for a license from the United States Small Business Administration to operate as a Small Business Investment Company, or SBIC. This is the second SBIC license granted to the Company through its SBIC subsidiaries. The license will allow Stellus SBIC to obtain leverage by issuing SBA-guaranteed debentures, subject to the issuance of a capital commitment by the SBA and customary procedures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The interest rate is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with ten-year maturities. Current statutes and regulations permit Stellus Capital SBIC II, L.P. to borrow up to a maximum of $175M in SBA-guaranteed debentures, subject to required capitalization of the SBIC subsidiary and other requirements.
|